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Nicholas Christakis, David Bangsberg, Allan Brandt and Arthur Kleinman  Sae Takada 
 
Quality of life, health-related stigma, and the social context: longitudinal analyses of 
PLWHA in Uganda and a literature review 
The dissertation examines the experience of living with stigmatized health conditions in 
the social context.  
The first paper examines the dynamic, bi-directional relationship between social support 
and HIV-related stigma. I use data from a prospective cohort of people living with HIV/AIDS 
(PLWHA) initiating antiretroviral therapy in rural Uganda. I use multilevel regression to model 
the contemporaneous and time-lagged relationships between two dimensions of stigma and 
social support. The results suggest that the two dimensions of stigma may compromise the ability 
to maintain and access social support. I also found that social support may be protective against 
future experiences of discrimination.  
The second paper examines the trajectory and determinants of health-related quality of 
life (HRQOL) of PLWHA initiating antiretroviral therapy. Using the same data set as paper one, 
I compared two types of multilevel models for change in which HRQOL is specified as linear 
and quadratic functions of time. Analyses indicated that HRQOL follows a quadratic trajectory 
that is concave to the time axis. Self-reported symptoms, food insecurity, and HIV-related stigma 
are negatively correlated with HRQOL, suggesting the importance of addressing social and 
economic situations of PLWHA in addition to clinical symptoms.  
The third paper is an interdisciplinary review of health-related stigma. The social 
psychology literature describes stigma as a product of individual traits and personalities that has 
roots in the biological instinct to avoid poor partners of social exchange. In contrast, the 
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historical, anthropological, and autobiographical literatures highlight the role of social forces 
outside of the individual in the production of stigma. I argue that health-related stigma is based 
on the ever-changing understandings about disease causality that reflects contemporary ideas 
about morality. Further, stigmatization is contingent on a social structure in which differential 
access to social, economic and political power determines who is stigmatized. Finally, 
stigmatization dehumanizes individuals who are already vulnerable, and erects barriers to health 
and social resources to further exacerbate social inequalities. Therefore, health-related stigma 
should not be used as a tool to promote public health, and societal efforts should focus on 
eliminating health-related stigma.  
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CHAPTER 1 
 
Health-related quality of life among people living with HIV/AIDS initiating antiretroviral 
therapy in rural Uganda 
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INTRODUCTION 
The health-related quality of life (HRQOL) has become a priority in the care of people 
living with HIV/AIDS (PLWHA), especially as access to Highly Active Antiretroviral Therapy 
(HAART) expands across the globe, making HIV/AIDS a long-term chronic, rather than an 
acute,  condition.  Measure  of  HRQOL  captures  not  only  the  subject’s  appraisal  of  health  status  
but also its impact on functional status such as the ability to perform self-care and daily 
activities, decreased pain and discomfort, improved strength and appetite, and improved mental 
functioning.1-3 Such self-reported HRQOL is valuable because it can allow the assessment of the 
experience of illness that cannot be evaluated by medical experts,4 and has been correlated with 
other measures of overall wellbeing such as happiness.5 
Many studies of PLWHA report improvement in the HRQOL after being treated with 
HAART, either compared to pre-treatment baseline or compared to their untreated counterparts.6-
8 These improvements have in part been attributed to improvements in immunologic outcomes 
from HAART. PLWHA on HAART have reported increases in CD4 count and reduction in 
detectable viral load,9 and these clinical indicators have been consistently associated with 
improvements in reports of both physical and mental aspects of HRQOL.1,6,9,10  
Non-health circumstances such as access to basic economic and social resources are 
believed to have a significant impact on HRQOL, particularly in resource-poor settings and 
vulnerable populations.11 While there is an emerging interest in examining the correlates of 
HRQOL among PLWHA that are outside the domain of clinical indicators, there is limited 
systematic exploration of the relationship between social and economic factors and HRQOL of 
PLWHA.  
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Various indicators of poor economic situation have been consistently negatively 
correlated with HRQOL. In sub-Saharan Africa, PLWHA who owned fewer household goods 
and depended on others for their main source of income reported lower both physical and mental 
components of health-related quality of health.1,6,12 Among the homeless in the US, those who 
reported unmet subsistence needs reported lower physical HRQOL.13 Even among populations 
who are not considered particularly vulnerable in the United States and Europe, lower education, 
poorer housing, lower income and unemployment predicted lower HRQOL.8,10,14,15 Evidence 
suggests that the positive association between economic wellbeing and HRQOL could be 
because patients placed on HAART partially regain their ability to work,3,16,17 and consequently 
have access better nutrition.2 Recently, Weiser and colleagues have indeed found that food 
security and quality of life were inversely correlated across time after initiation of HAART.18 
Social factors have been strongly associated with measures of health-related quality of 
life among PLWHA as well.10,19,20 Studies on the effect of social support on PLWHA have 
shown that social support has positive effects on PLWHA including less depression, improved 
coping with their disease, positive health behaviors, and slower progression of disease.21-24 
Social support may contribute to the HRQOL of PLWHA by enabling them to take part in the 
life of the community, as well as to access more tangible resources through friends and family. 
(Sen, Social Exclusion) Further, a handful of studies have examined the relationship between 
HIV-related stigma and HRQOL among PLWHA. Three cross-sectional studies found that high 
reports of HIV-stigma correlated with low measures of HRQOL, and one longitudinal study 
found that stigma was correlated with lower initial status of QOL.25 An extensive literature exists 
outside of the HRQOL literature on how stigma negatively impacts the psychosocial wellbeing 
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of PLWHA, including stress, fear, anxiety, and depression26-29 as well as poor engagement with 
care.30,31 
 Another aspect of debate is the trajectory of HRQOL once a PLWHA is placed on 
HAART. Some studies have shown steady improvement that was sustained for the duration of 
the study, which ranged from one1,25 to three years,16 accompanied by an increase in labor force 
participation.32 Some studies have found an initial upward trajectory of quality of health, 
followed by a plateau. The duration of the increase in quality of health varied by study, ranging 
from one month,32 three months,2 six to nine months,33 and one year15 after initiation of HAART. 
Finally, some studies found no change,9 or a deterioration in the quality of health.8,34 
Understanding the trajectory of HRQOL is important, because it would allow clinicians and 
public health programs to be vigilant for declines in HRQOL at critical times and to time the 
delivery medical or social services to modify the trajectory at critical times.   
The discrepancies of these studies may reflect some of the methodological limitations of 
these studies. First, the duration of these studies are as short as one year,1,8,12 which limits the 
ability to detect the longer-term trajectory. Second, is the limited number of time points at which 
data is collected, which limits the analytic methods as discussed below. Third, the sample size of 
many of these studies is limited.9 Fourth, many of the studies rely on inadequate analytic models 
to detect change in HRQOL. One such method is statistical comparison of group means between 
baseline and an end-point.8 Two waves of longitudinal data represent an extremely limited 
design for investigating change because the amount of change between the first and second 
occasions  of  measurement  cannot  tell  us  anything  about  the  shape  of  each  person’s  individual  
growth trajectory between those times, and estimates of true change are difficult to obtain from 
the observed two-wave data.35 Another method is regression models with duration of treatment 
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as dummy variables to analyze the effect of time on treatment on HRQOL,1,16 which also cannot 
tell us the shape of the trajectory. Finally, the studies are limited in the social and economic 
variables that are examined as controls and covariates. These problems limit the ability to detect 
the true trajectory and determinants of the HRQOL of PLWHA on HAART.  
 The goal of this study is to contribute to the literature on the determinants and the 
trajectory of physical and mental quality of health among PLWHA on HAART in a resource 
poor setting.   
METHODS 
 We used data from an ongoing, prospective cohort of PLWHA taking antiretroviral 
therapy (ART) in rural Uganda. Eligibility criteria included having no prior history of treatment 
with HIV ART, being over 18 years of age, and living within 20 km of the Immune Suppression 
Syndrome (ISS) Clinic at the Mbarara Regional Referral Hospital. The ISS Clinic is located in 
Mbarara District, 275 km southwest of Kampala, and provides free ART for people living with 
HIV/AIDS in southwestern Uganda, Rwanda and the Democratic Republic of Congo.36 The 
majority of the population in Mbarara district is ethnically Ankole, and the local language is 
Runyankole. The local economy is largely based on subsistence agriculture.  
Our analyses are based on data from participants who were enrolled into the cohort from 
2007 through 2010. Survey questions were translated into Runyankole, back-translated into 
English, further modified through focus groups with key informants, and pilot-tested to ensure 
clarity and relevance. Trained research assistants who spoke Runyankole interviewed 
participants every three months in a private room at the site research office near the ISS Clinic. 
Each survey took approximately one hour to complete.  
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Informed consent was obtained from all study participants. Ethical approval for all study 
procedures was obtained by the Committee on Human Research, University of California at San 
Francisco; the Partners Human Research Committee at Massachusetts General Hospital; and the 
Institutional Ethical Review Committee, Mbarara University of Science and Technology.   
 Study variables were assessed at baseline and at each quarterly follow-up interview using 
the scales described below.  
Health-related quality of life 
The primary outcomes are the physical health summary (PHS) and mental health 
summary (MHS) scores of the Medical Outcome Study-HIV (MOS-HIV).37,38 MOS-HIV is 35-
item questionnaire used widely in research and clinical trials of treatments with HIV-infection, 
and has shown very good internal consistency, construct validity, test-retest reliability, have 
good discriminant validity and clinical responsiveness in a variety of settings39,40 including rural 
Uganda.12 MOS-HIV assesses multiple dimensions of HRQOL, including perceived ability to 
work and perform daily role, perceived health functioning, perceived vitality, memory and 
reasoning, affect, and a self-rating of perceived general health. Factor analyses have consistently 
identified physical health (PHS) and mental health factors (MHS) that are used as summary 
indicators.40 A higher score reflects a better health-related quality of life.  
Clinical Indicators 
 In our regression models, we adjusted for self-reported symptoms, depression, and CD4+ 
T-lymphocyte cell count. I measured 32 symptoms, such as headache, pain, and fatigue, and 
created a summary index composed of equally weighted average of z-scores of its components as 
described by Kling and colleagues, with higher scores indicating a greater symptoms burden.41 
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Because prior studies have shown that depression is associated with HRQOL,20,34 I also adjusted 
for depression symptom severity. We measured depression using a version of the 15-item 
Hopkins Symptom Checklist for Depression42 that was adapted to the local context with the 
addition  of  a  16th  item,  “feeling  like  I  don’t  care  about  my  health.”  27,43 I restricted the 
calculation of the score to the 12 affective items in light of prior research suggesting that the 
somatic items overlap with symptoms of HIV infection and may inflate the prevalence of 
depression among PLWHA.44,45 Participants were classified as having probable depression based 
on the conventional threshold score of 1.75.46  
Economic Indicators 
 I examined the following economic indicators: asset ownership, unemployment, and food 
insecurity. I measured baseline asset ownership using a household asset index,47 which was 
entered into the models as a continuous variable, with higher values of the asset index indicating 
greater household wealth relative to other households in the sample. I used the Household food 
insecurity access scale (HFIAS) to measure food insecurity. This nine-item scale asks about 
uncertainty or anxiety over food, perceptions about quantity, quality, reduction of food intake, 
consequences  of  reduced  food  intake,  shame.  These  questions  attempt  to  capture  the  household’s  
perception  of  changes  to  the  quality  of  their  diet  regardless  of  the  diet’s  objective  nutritional  
composition. Participants were identified as being food secure, or mildly, moderately, and 
severely food insecure.  
Social Indicators 
 I examined social support, internalized stigma, and enacted stigma for our social 
indicators. I measured social support using the Social Support Scale,48 which contains 10 items 
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about instrumental and emotional social support. High scores reflect higher levels of social 
support. This scale is adapted from the Duke-University of North Carolina Functional Social 
Support Questionnaire, which was designed to measure multiple dimensions of social support 
among patients in a primary care setting.49 Internalized HIV stigma was measured using the 
Internalized AIDS-Related Stigma Scale, which contains six items corresponding to the guilt, 
shame,  and  worthlessness  in  Goffman’s  conceptualization  of  stigma.50-52 To measure enacted 
stigma, we asked participants about whether they had experienced 14 discriminatory events in 
the past three months as a result of their HIV status, such as abandonment, housing, or property 
loss, or physical violence.53 The enacted stigma scale was calculated as the sum of the 14 items, 
with higher scores indicating greater intensity of enacted stigma experienced. 
Finally, I adjusted for a range of other baseline (time-invariant) demographic covariates 
with potential for influencing HRQOL. We adjusted for baseline age, sex, educational attainment 
and marital status. Time was measured in years since starting HAART. 
Data analysis 
I used multilevel model for change to investigate the change in HRQOL over time. The 
dependent variable used in these analyses was HRQOL as measured in the PHS and MHS 
components of MOS-HIV. The multilevel model for change simultaneously uses data on all 
individuals at every time-point to concurrently investigate within- and between-individual 
change. Further, with the multiwave data, the model permits the flexible specification and rich 
investigation of nonlinear individual change over time. The multilevel model for change 
hypothesizes that, for each individual, the continuous outcome variable is a specified function of 
time plus error.54 For my level-1 submodel that describes how HRQOL in each individual 
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changes over time, we specified two types of trajectories. The first model stipulates that HRQOL 
has a linear relationship with time. The second model stipulated that HRQOL has a curvilinear 
relationship with time. Based on examination of preliminary empirical growth plots, I decided to 
use a polynomial growth model containing a quadratic function of time. Once an individual 
growth trajectory is specified to represent individual change over time, I specified a level-2 
submodel that describes how these changes differ across individuals. In my analyses, the 
hypothesized levels 1 and 2 statistical models were fitted simultaneously to the data using PROC 
MIXED on SAS statistical software (version 9.2, SAS Institute Inc., Cary, North Carolina).  
I conducted the analyses sequentially. I initially conducted a set of unconditional growth 
analyses in which I posited a linear individual change trajectory at level 1, but did not attempt to 
predict inter-individual variation in the growth parameters by between-subject factors. Second, I 
conducted a set of conditional analyses in which I examined systematic inter-individual 
differences in intercept, slope, and curvature using between-subject predictors: demographics, 
clinical, economic, and social variables.  
RESULTS 
  The total sample size was 422. Table 1.1 summarizes baseline characteristics of the 
respondents. Women were slightly overrepresented in the sample (71% women v 29% men). The 
mean age was 34 years, and participants were followed for a median duration of 2.08 years. 
Forty-four percent of participants were married, 85% had a primary school education or more. At 
baseline, sixteen percent of participants were depressed, the median symptom index was 0.066, 
and the median CD4 cell count was 203 cells/mm3. Twenty-nine percent of participants were 
unemployed, and 39% were severely food insecure. Participants cored an median of 1 point on 
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the internalized stigma scale, 0 points on the enacted stigma scale, and 3.9 points on the social 
support scale.  
Table 1.1 Participant Baseline Characteristics (N=422)  
Characteristic  N (%) or median (Q1-Q3) 
Gender   
 Female 298 (71%) 
 Male 124 (29%) 
Age at start of study  34.08 years (29.01-40.00) 
Time in study  2.08 years (1.82-2.79) 
Marital status   
 Not married 238 (56%) 
 Married 184 (44%) 
Education   
 None 65 (15%) 
 Primary or more 357 (85%) 
Depression  67 (16%) 
Symptom Index  0.066 (-0.16 – 0.52) 
CD4 count  203 cells/mm3 (129-294) 
Unemployed  124 (29%) 
Severely Food 
Insecure 
 164 (39%) 
Internalized stigma 6-item scale 1 (0-2) 
Enacted stigma 14-item scale 0 (0-0) 
Social support 4-point scale 3.9 (3.5-4.0) 
 
Table 1.2 shows the taxonomy of multivariate multilevel model for change for the effect 
of time on PHS. There are eight pairs of linear (level-1 model stipulates that HRQOL has a linear 
relationship with TIME) and quadratic models (level-1 model stipulates a quadratic growth 
model of HRQOL containing TIME and TIME2) that adjust for level-2 predictors to explain any 
between-individual differences in HRQOL initial state and trajectory. Using the unconditional 
analyses I computed the intraclass correlation of PHS, which compares the relative magnitude of 
the variance components by estimating the proportion of total variation in PHS that is between 
individuals. The intraclass correlation for PHS was 0.42, signifying that over 50% of the total 
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variation in both quality of life indicators is attributable to differences within individuals over 
time. 
For all pairs of quadratic and linear models fitted for PHS, intermodal comparisons of 
goodness-of-fit statistics showed that the quadratic models better describe the relationship 
between HRQOL and TIME, and that the inclusion of demographic, social, and economic 
predictors significantly improved the fit. For example, comparing the fully-adjusted quadratic 
model with the fully-adjusted linear model, the deviance statistic declines by 44.2. This exceeds 
the 0.01 critical value of a chi-square distribution on four degrees of freedom (TIME2 and the 
variance and covariance parameters), so we reject the null hypothesis that the four additional 
parameters are simultaneously zero, and conclude that the quadratic growth model better 
describes the relationship between HRQOL and TIME.  
 The trajectory of PHS with time described by the fully-adjusted quadratic model gives 
the instantaneous rate of change of PHS at TIME=0 as 1.80 (95% CI 0.72, 2.89, p=0.0012), and 
the curvature parameter associated with TIME2 that signifies the changing rate of change as -
0.54 (95% CI -0.82, -0.25, p=0.0003). This means that the trajectory is concave to the time axis, 
in which PHS initially rises at the start of treatment, peaks at 1.67 years after initiating treatment 
and declines.  
 This fully adjusted quadratic model shows that age is negatively correlated with PHS (b = 
-0.071, 95% CI -0.14, -0.0043, p=0.04). Both self-reported symptoms (b= -10.61, 95% CI -
11.48, -9.74, p<0.0001) and depression (b = -2.74, 95% CI -3.95, -1.53, p<0.0001) are negatively 
correlated with PHS, while CD4 count is not (b = 0.11, 95% CI -0.085, 0.30, p=0.28). Notably, 
the effect of TIME and TIME2 on PHS is significantly attenuated with the addition of self-
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reported symptoms into the model, although the effects of both still remain statistically 
significant. Food insecurity has a negative relationship with PHS that remains fairly stable even 
after adjusting for other factors (b = -0.42, 95% CI -0.67, -0.16, p=0.0016). Asset ownership 
does not show a statistically significant relationship with PHS (b= 0.084, 95% CI -0.30, 0.47, 
p=0.67), and the effect of unemployment is attenuated when food insecurity is added to the 
model (b = -0.071, 95% CI -0.14, -0.0043, p=0.04). Both internalized stigma (b = -0.38, 95% CI 
-0.59, -0.18, p=0.0002) and enacted stigma (b = -0.88, 95% CI -1.30, -0.45, p<0.0001) are 
negatively correlated with PHS, while social support does not have a statistically significant 
relationship with PHS at the level of p<0.05 (b = 0.28, 95% CI -0.37, 0.94, p=0.39).  
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Table 1.2 Taxonomy of multilevel models describing the relationship between PHS and time, controlling for 
demographic, clinical, economic, and social variables 
* p<0.05, ** p<0.01, *** p<0.001  
 Unadjusted model Unadjusted model, Time2 Adjusted for 
demographics 
Adjusted for 
demographics, Time2 
 Beta (95% Confidence 
Interval [CI]) 
Beta (95% CI) Beta (95% CI) Beta (95% CI) 
Fixed Effects     
Intercept 47.36*** (46.32, 48.39) 44.79***(43.56, 46.02) 52.85*** (48.92, 56.78) 49.17***(45.23, 53.11) 
Time 2.21*** (1.71, 2.71) 7.02*** (5.67, 8.37) 2.24*** (1.74, 2.74) 7.08*** (5.73, 8.43) 
Time2  -1.66*** (-2.03, -1.27)  -1.67*** (-2.06, -1.28) 
Sex (Female)   -1.97** (-3.43, -0.51) -1.65* (-3.09, -0.22) 
Marital Status (Married)   -0.66 (-1.68, 0.36) -0.56 (-1.55, 0.42) 
Education (Primary school 
and above) 
  1.43 (-0.30, 3.17) 1.91* (0.19, 3.62) 
Age   -0.14*** (-0.22, -0.07) -0.13*** (-0.21, -0.05) 
Symptom Index     
Depression     
CD4 T cell count *100     
Asset Ownership     
Unemployed     
Food Insecurity     
Internalized Stigma     
Enacted Stigma     
Social Support     
Variance Components     
L1: within person 44.42*** 41.14*** 44.42*** 41.09*** 
L2: btwn person variance 
in intercept 
72.47*** 84.49*** 70.84*** 83.81*** 
L2: btwn person variance 
in rate of change 
11.69*** 79.21*** 11.67*** 80.12*** 
L2: btwn person variance 
in curvature 
 14.14***  5.80*** 
Goodness-of-fit     
-2LL 19172.0 19033.8 19151.3 19013.3 
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Table 1.2 Continued 
 Adjusted for 
demographics and 
symptoms 
Demographics, 
symptoms, Time2 
Demographics, 
symptoms, depression  
Demographics, 
symptoms, depression, 
with Time2 
 Beta (95% CI) Beta (95% CI) Beta (95% CI) Beta (95% CI) 
Fixed Effects     
Intercept 51.93***(48.52, 55.34) 50.16*** (46.71, 53.60) 52.21*** (48.81, 55.61) 50.48*** (47.05, 53.91) 
Time 0.20 (-0.21, 0.61) 2.17*** (1.06, 3.27) 0.17 (-0.24, 0.58) 2.06*** (0.96, 3.16) 
Time2  -0.61*** (-0.91, -0.32)  -0.59*** (-0.89, -0.30) 
Sex (Female) -0.015 (-1.30, 1.27) 0.18 (-1.09, 1.45) 0.018 (-1.26, 1.29) 0.23 (-1.04, 1.49) 
Marital Status (Married) -0.28 (-1.16, 0.61) -0.18 (-1.05, 0.69) -0.25 (-1.13, 0.63) -0.15 (-1.02, 0.71) 
Education (Primary 
school and above) 
0.99 (-0.53, 2.50) 1.09 (-0.42, 2.60) 1.01 (-0.50, 2.52) 1.11 (-0.39, 2.61) 
Age -0.076*(-0.14, -0.0077) -0.066 (-0.13, 0.0022) -0.079* (-0.15, -0.011) -0.069* (-0.14, -0.00092) 
Symptom Index -12.18*** (-12.97, -11.39) -11.78*** (-12.60, -10.97) -11.45*** (-12.29, -10.61) -11.06*** (-11.92, -10.19) 
Depression   -2.94*** (-4.15, -1.72) -2.94*** (-4.16, -1.73) 
CD4 cell count *100     
Asset Ownership     
Unemployed     
Food Insecurity      
Internalized Stigma     
Enacted Stigma     
Social Support     
Variance Components     
L1: within person 31.59*** 31.59*** 32.80*** 31.37*** 
L2: btwn person variance 
in intercept 
50.83*** 50.83*** 43.24*** 50.48*** 
L2: btwn person variance 
in rate of change 
36.99*** 36.99*** 5.12*** 37.34*** 
L2: btwn person variance 
in curvature 
2.10** 2.10**  2.15** 
Goodness-of-fit     
-2LL 18046.2 18046.2 18070.9 18023.8 
* p<0.05, ** p<0.01, *** p<0.001  
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Table 1.2 Continued 
 Demographics, 
symptoms, depression, 
CD4 
Demographics, 
symptoms, depression, 
CD4 with Time2 
Demographics, 
symptoms, depression, 
CD4, wealth and 
unemployment  
Demographics, 
symptoms, depression, 
CD4, wealth and 
unemployment with 
Time2 
 Beta (95% CI) Beta (95% CI) Beta (95% CI) Beta (95% CI) 
Fixed Effects     
Intercept 52.01*** (48.59, 55.43) 50.27***(46.82, 53.73) 51.96*** (48.48, 55.44) 50.11*** (46.61, 53.62) 
Time 0.11 (-0.33, 0.54) 2.00*** (0.89, 3.11) 0.098 (-0.33, 0.53) 2.00*** (0.89, 3.10) 
Time2  -0.59*** (-0.89, -0.30)  -0.59*** (-0.89, -0.30) 
Sex (Female) -0.023 (-1.30, 1.26) 0.18 (-1.02, 1.45) 0.15 (-1.14, 1.43) 0.39 (-0.89, 1.66) 
Marital Status (Married) -0.25 (-1.13, 0.63) -0.15 (-1.02, 0.71) -0.26 (-1.15, 0.62) -0.18 (-1.05, 0.69) 
Education (Primary 
school and above) 
1.01 (-0.50, 2.52) 1.12 (-0.39, 2.62) 0.90 (-0.62, 2.41) 0.96 (-0.54, 2.47) 
Age -0.078* (-0.15, -0.0097) -0.068 (-0.14, 0.00) -0.082* (-0.15, -0.014) -0.073* (-0.14, -0.0047) 
Symptom Index -11.43*** (-12.27, -10.59) -11.04*** (-11.90, -10.17) -11.42*** (-12.27, -10.58) -11.02*** (-11.88, -10.15) 
Depression -2.92*** (-4.14, -1.70) -2.92*** (-4.14, -1.71) -2.95***(-4.17, -1.73) -2.96*** (-4.18, -1.75) 
CD4 cell count *100 0.092 (-0.10, 0.29) 0.095 (-0.099, 0.29) 0.09214 (-0.10, 0.29) 0.096 (-0.097, 0.29) 
Asset Ownership   0.14 (-0.26, 0.53) 0.19 (-0.20, 0.58) 
Unemployed   -0.70 (-1.46, 0.064) -0.77* (-1.54, -0.012) 
Food Insecurity     
Internalized Stigma     
Enacted Stigma     
Social Support     
Variance Components     
L1: within person 32.81*** 31.37*** 32.85*** 31.40*** 
L2: btwn person variance 
in intercept 
43.07*** 50.71*** 42.45*** 49.56*** 
L2: btwn person variance 
in rate of change 
5.07*** 37.44*** 4.90*** 36.82*** 
L2: btwn person variance 
in curvature 
 2.17**  2.08** 
Goodness-of-fit     
-2LL 18070.1 18022.9 18066.2 18017.9 
* p<0.05, ** p<0.01, *** p<0.001 
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Table 1.2 Continued 
 Demographics, symptoms, 
depression, CD4, wealth, 
unemployment, and FI  
Demographics, symptoms, 
depression, CD4, wealth, 
unemployment, and FI 
with Time2 
Demographics, symptoms, 
depression, CD4, wealth, 
unemployment, FI, stigma, 
and social support  
Demographics, symptoms, 
depression, CD4, wealth, 
unemployment, FI, stigma, 
and social support with Time2 
 Beta (95% CI) Beta (95% CI) Beta (95% CI) Beta (95% CI) 
Fixed Effects     
Intercept 53.25*** (49.73, 56.77) 51.36*** (47.80, 54.92) 52.78*** (48.51, 57.04) 50.98*** (46.71, 55.25) 
Time 0.081 (-0.34, 0.51) 1.87*** (0.78, 2.97) 0.091 (-0.33, 0.51) 1.80** (0.72, 2.89) 
Time2  -0.56*** (-0.85, -0.27)  -0.54*** (-0.82, -0.25) 
Sex (Female) 0.23 (-1.05, 1.50) 0.45 (-0.81, 1.72) 0.34 (-0.92, 1.60) 0.54 (-0.70, 1.79) 
Marital Status (Married) -0.29 (-1.18, 0.59) -0.21 (-1.08, 0.66) -0.33 (-1.21, 0.54) -0.25 (-1.11, 0.61) 
Education (Primary 
school and above) 
0.92 (-0.58, 2.43) 0.98 (-0.52, 2.48) 0.86 (-0.62, 2.35) 0.93 (-0.55, 2.40) 
Age -0.072* (-0.14, -0.0041) -0.065 (-0.13, 0.0031) -0.078* (-0.14, -0.010) -0.071* (-0.14, -0.0043) 
Symptom Index -11.25*** (-12.09, -10.40) -10.87*** (-11.74, -10.00) -10.96*** (-11.81, -10.12) -10.61*** (-11.48, -9.74) 
Depression -2.92*** (-4.13, -1.70) -2.93*** (-4.15, -1.72) -2.72*** (-3.93, -1.51) -2.74*** (-3.95, -1.53) 
CD4 cell count *100 0.091 (-0.10, 0.28) 0.093 (-0.10, 0.29) 0.11 (-0.087, 0.30) 0.11 (-0.085, 0.30) 
Asset Ownership 0.03 (-0.36, 0.43) 0.096 (-0.30, 0.49) 0.035 (-0.35, 0.43) 0.084 (-0.30, 0.47) 
Unemployed -0.57 (-1.33, 0.19) -0.66 (-1.42, 0.11) -0.53 (-1.28, 0.22) -0.61 (-1.36, 0.15) 
Food Insecurity -0.52*** (-0.78, -0.27) -0.46*** (-0.72, -0.20) -0.47*** (-0.73, -0.21) -0.42** (-0.67, -0.16) 
Internalized Stigma   -0.40*** (-0.60, -0.19) -0.38*** (-0.59, -0.18) 
Enacted Stigma   -0.87*** (-1.29, -0.44) -0.88*** (-1.30, -0.45) 
Social Support   0.26*** (-0.40, 0.92) 0.28 (-0.37, 0.94) 
Variance Components     
L1: within person 32.84*** 31.40*** 32.64*** 31.27*** 
L2: btwn person 
variance in intercept 
42.71*** 49.89*** 40.70*** 48.85*** 
L2: btwn person 
variance in rate of 
change 
4.51*** 35.46*** 4.26*** 35.15*** 
L2: btwn person 
variance in curvature 
 2.02**  2.01** 
Goodness-of-fit     
-2LL 18050.7 18005.8 18018.2 17974.0 
* p<0.05, ** p<0.01, *** p<0.001 
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Table 1.3 shows the taxonomy of multivariate multilevel model for change for the effect 
of time on PHS. There are eight pairs of linear (level-1 model stipulates that HRQOL has a linear 
relationship with TIME) and quadratic models (level-1 model stipulates a quadratic growth 
model of HRQOL containing TIME and TIME2) that adjust for level-2 predictors to explain any 
between-individual differences in HRQOL initial state and trajectory. The intraclass correlation 
for MHS was 0.48, signifying that over 50% of the total variation in both quality of life 
indicators is attributable to differences within individuals over time. Similarly to models for 
PHS, intermodal comparisons of goodness-of-fit statistics showed that the quadratic models 
better describe the relationship between HRQOL and TIME, and that the inclusion of 
demographic, social, and economic predictors significantly improved the fit.  
 The trajectory of MHS with time described by the fully-adjusted quadratic model gives 
an instantaneous rate of change of MHS at TIME=0 as 1.35 (95% CI 0.38, 2.32, p=0.0064), and 
the curvature parameter associated with TIME2 that signifies the changing rate of change as -
0.31 (95% CI -0.55, -0.076, p=0.0097). This means that the trajectory is concave to the time axis, 
in which MHS initially rises at the start of treatment, peaks at 2.18 years after initiating treatment 
and declines.  
 This fully adjusted quadratic model shows both self-reported symptoms (b= -10.30, 95% 
CI -11.10, -9.50, p<0.0001) and depression (b = -6.69, 95% CI -7.81, -5.58, p<0.0001) are 
negatively correlated with MHS, while CD4 count is not (b = 0.14, 95% CI -0.036, 0.32, 
p=0.12). Similarly to the PHS models, the effect of TIME and TIME2 on MHS is significantly 
attenuated with the addition of self-reported symptoms into the model, although the effects of 
both still remain statistically significant. Both food insecurity (b = -1.11, 95% CI -1.35, -0.87, 
p=0.0001) and unemployment (b = -0.86, 95% CI -1.56, -0.16, p=0.016) have a negative 
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relationship with MHS. Asset ownership does not show a statistically significant relationship 
with MHS (b= 0.13, 95% CI –0.22, 0.48, p=0.46). Both internalized stigma (b = -0.44, 95% CI -
0.62, -0.25, p<0.0001) and enacted stigma (b = -0.54, 95% CI -0.93, -0.14, p<0.0075) are 
positively correlated with MHS, while social support does not have a statistically significant 
relationship with MHS at the level of p<0.05 (b = 0.18, 95% CI -0.42, 0.79, p=0.55). 
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Table 1.3 Taxonomy of multilevel models describing the relationship between MHS and time, controlling for 
demographic, clinical, economic, and social variables 
 Unadjusted model Unadjusted model, Time2 Adjusted for 
demographics 
Adjusted for 
demographics, Time2 
 b (95% CI) b (95% CI) b (95% CI) b (95% CI) 
Fixed Effects     
Intercept 46.23*** (45.14, 47.31) 43.87*** (42.58, 45.16) 50.22*** (46.08, 54.37) 47.05*** (42.95, 51.14) 
Time 2.79*** (2.25, 3.33) 6.91*** (5.61, 8.22) 2.82*** (2.28, 3.36) 6.96*** (5.65, 8.27) 
Time2  -1.43*** (-1.78, -1.07)  -1.43*** (-1.79, -1.08) 
Sex (Female)   -2.67*** (-4.21, -1.12) -2.46** (-3.96, -0.97) 
Marital Status (Married)   -0.67 (-1.68, 0.35) -0.59 (-1.58, 0.39) 
Education (Primary school 
and above) 
  0.72 (-1.12, 2.55) 1.12 (-0.67, 2.92) 
Age   -0.070 (-0.15, 0.013) -0.062 (-0.14, 0.019) 
Symptom Index     
Depression     
CD4 cell count *100     
Asset Ownership     
Unemployed     
Food Insecurity     
Internalized Stigma     
Enacted Stigma     
Social Support     
Variance Components     
L1: within person 38.78*** 36.98*** 38.84*** 36.96*** 
L2: btwn person variance 
in intercept 
89.46*** 95.02*** 85.68*** 90.47*** 
L2: btwn person variance 
in rate of change 
17.36*** 65.29*** 17.22*** 65.57*** 
L2: btwn person variance 
in curvature 
 3.43*  3.54* 
Goodness-of-fit     
-2LL 18993.7 18881.5 18980.2 18868.1 
* p<0.05, ** p<0.01, *** p<0.001 
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Table 1.3 Continued 
 Adjusted for demographics 
and symptoms 
Demographics, symptoms, 
Time2 
Demographics, symptoms, 
depression  
Demographics, symptoms, 
depression, with Time2 
 b (95% CI) b (95% CI) b (95% CI) b (95% CI) 
Fixed Effects     
Intercept 49.68*** (46.33, 53.01) 48.84*** (45.47, 52.21) 50.32*** (47.11, 53.54) 49.53*** (46.29, 52.77) 
Time 0.65** (0.21, 1.10) 1.91*** (0.86, 2.96) 0.58** (0.17, 1.00) 1.73*** (0.73, 2.74) 
Time2  -0.41** (-0.67, -0.15)  -0.38** (-0.63, -0.13) 
Sex (Female) -0.75 (-2.01, 0.50) -0.70 (-1.94, 0.55) -0.66 (-1.87, 0.56) -0.59 (-1.79, 0.61) 
Marital Status (Married) -0.38 (-1.22, 0.47) -0.31 (-1.14, 0.53) -0.32 (-1.15, 0.50) -0.25 (-1.06, 0.56) 
Education (Primary school 
and above) 
0.19 (-1.30, 1.66) 0.15 (-1.32, 1.62) 0.19 (-1.24, 1.61) 0.15 (-1.27, 1.57) 
Age -0.0074 (-0.074, 0.060) -0.0052 (-0.072, 0.061) -0.013 (-0.078, 0.052) -0.010 (-0.074, 0.054) 
Symptom Index -12.79*** (-13.55, -12.03) -12.61*** (-13.39, -11.84) -11.11*** (-11.89, -10.32) -10.95*** (-11.76, -10.14) 
Depression   -6.92*** (-8.06, -5.79) -6.85*** (-7.98, -5.72) 
CD4 cell count *100     
Asset Ownership     
Unemployed     
Food Insecurity      
Internalized Stigma     
Enacted Stigma     
Social Support     
Variance Components     
L1: within person 28.57*** 27.85*** 27.61*** 26.90*** 
L2: btwn person variance in 
intercept 
46.48*** 56.70*** 38.66*** 46.73*** 
L2: btwn person variance in 
rate of change 
8.87*** 33.33*** 7.14*** 28.59*** 
L2: btwn person variance in 
curvature 
 0.98*  0.89* 
Goodness-of-fit     
-2LL 17836.6 17794.8 17697.6 17659.1 
* p<0.05, ** p<0.01, *** p<0.001 
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Table 1.3 Continued 
 Demographics, 
symptoms, depression, 
CD4 
Demographics, 
symptoms, depression, 
CD4 with Time2 
Demographics, 
symptoms, depression, 
CD4, wealth and 
unemployment  
Demographics, 
symptoms, depression, 
CD4, wealth, 
unemployment, Time2 
 B (95% CI) B (95% CI) B (95% CI) B (95% CI) 
Fixed Effects     
Intercept 49.98*** (46.73, 53.23) 49.20*** (45.92, 52.47) 49.69*** (46.41, 52.97) 48.92*** (45.62, 52.22) 
Time 0.47* (0.031, 0.91) 1.63** (0.61, 2.64) 0.46* (0.024, 0.89) 1.65** (0.65, 2.66) 
Time2  -0.38** (-0.63, -0.13)  -0.39** (-0.64, -0.14) 
Sex (Female) -0.72 (-1.94, 0.50) -0.65 (-1.86, 0.55) -0.46 (-1.68, 0.75) -0.36 (-1.56, 0.84) 
Marital Status (Married) -0.32 (-1.14, 0.50) -0.24 (-1.06, 0.57) -0.39 (-1.22, 0.43) -0.31 (-1.13, 0.50) 
Education (Primary 
school and above) 
0.19 (-1.24, 1.62) 0.16 (-1.27, 1.58) -0.053 (-1.48, 1.37) -0.11 (-1.53, 1.31) 
Age -0.011 (-0.076, 0.053) -0.0087 (-0.073, 0.056) -0.021 (0.086, 0.043) -0.019 (-0.084, 0.045) 
Symptom Index -11.07*** (-11.86, -10.28) -10.92*** (-11.73, -10.11) -11.04*** (-11.83, -10.26) -10.88*** (-11.68, -10.07) 
Depression -6.90*** (-8.03, -5.77) -6.82*** (-7.96, -5.69) -6.98*** (-8.11, -5.85) -6.91*** (-8.05, -5.78) 
CD4 cell count *100 0.15 (-0.030, 0.34) 0.15 (-0.033, 0.33) 0.15 (-0.030, 0.34) 0.15, (-0.033, 0.33) 
Asset Ownership   0.34 (-0.029, 0.72) 0.35 (-0.015, 0.72) 
Unemployed   -1.00** (-1.72, -0.29) -1.15** (-1.87, -0.43) 
Food Insecurity     
Internalized Stigma     
Enacted Stigma     
Social Support     
Variance Components     
L1: within person 27.58*** 26.87*** 27.67*** 26.94*** 
L2: btwn person variance 
in intercept 
38.68*** 46.67*** 36.84*** 44.41*** 
L2: btwn person variance 
in rate of change 
1.28*** 28.67*** 6.63*** 28.21*** 
L2: btwn person variance 
in curvature 
 0.93*  0.92* 
Goodness-of-fit     
-2LL 17695.0 17656.5 17683.7 17642.6 
* p<0.05, ** p<0.01, *** p<0.001 
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Table 1.3 continued 
 Demographics, symptoms, 
depression, CD4, wealth, 
unemployment, and FI  
Demographics, symptoms, 
depression, CD4, wealth, 
unemployment, and FI with 
Time2 
Demographics, symptoms, 
depression, CD4, wealth, 
unemployment, FI, 
stigma, and social support  
Demographics, symptoms, 
depression, CD4, wealth, 
unemployment, FI, stigma, and 
social support with Time2 
 b (95% CI) b (95% CI) b (95% CI) b (95% CI) 
Fixed Effects     
Intercept 52.65*** (49.44, 55.85) 51.95*** (48.71, 55.20) 52.36*** (48.49, 56.24) 51.92*** (48.04, 55.81) 
Time 0.42* (0.0016, 0.84) 1.43** (0.45, 2.41) 0.42* (0.0060, 0.83) 1.35** (0.38, 2.32) 
Time2  -0.33** (-0.57, -0.090)  -0.31* (-0.55, -0.073) 
Sex (Female) -0.23 (-1.39, 0.93) -0.12 (-1.28, 1.03) -0.16 (-1.29, 0.98) -0.045 (-1.17, 1.08) 
Marital Status (Married) -0.45 (-1.25, 0.36) -0.34 (-1.14, 0.45) -0.48 (-1.27, 0.31) -0.38 (-1.16, 0.41) 
Education (Primary 
school and above) 
-0.044 (-1.41, 1.32) -0.13 (-1.50, 1.23) -0.095 (-1.43, 1.24) -0.19 (-1.51, 1.14) 
Age -0.0010 (-0.063, 0.061) 0.0014 (-0.060, 0.063) -0.0074 (-0.068, 0.053) -0.0051 (-0.065, 0.055) 
Symptom Index -10.67*** (-8.02, -5.78) -10.53*** (-11.33, -9.73) -10.42*** (-11.20, -9.64) -10.29*** (-11.09, -9.49) 
Depression -6.90*** (-8.02, -5.78) -6.85*** (-7.97, -5.73) -6.75*** (-7.86, -5.63) -6.70*** (-7.82, -5.58) 
CD4 cell count *100 0.14 (-0.035, 0.32) 0.14 (-0.040, 0.32) 0.15 (-0.027, 0.33) 0.14 (-0.033, 0.32) 
Asset Ownership 0.103 (-0.26, 0.46) 0.12 (-0.24, 0.47) 0.13 (-0.22, 0.48) 0.13 (-0.22, 0.48) 
Unemployed -0.74* (-1.44, -0.035) -0.88* (-1.59, -0.18) -0.71* (-1.41, -0.014) -0.86* (-1.55, -0.16) 
Food Insecurity -1.16*** (-1.40, -0.92) -1.15*** (-1.39, -0.91) -1.11*** (-1.35, -0.88) -1.11*** (-1.35, -0.87) 
Internalized Stigma   -0.44*** (-0.63, -0.25) -0.44*** (-0.62, -0.25) 
Enacted Stigma   -0.48* (-0.88, -0.088) -0.54** (-0.93, -0.14) 
Social Support   0.22 (-0.39, 0.82) 0.18 (-0.42, 0.79) 
Variance Components     
L1: within person 27.25*** 26.55*** 27.30*** 26.61*** 
L2: btwn person variance 
in intercept 
36.05*** 45.36*** 32.90*** 42.47*** 
L2: btwn person variance 
in rate of change 
5.85*** 27.11*** 5.46*** 26.88*** 
L2: btwn person variance 
in curvature 
 0.90*  0.91* 
Goodness-of-fit     
-2LL 17596.1 17557.0 17568.2 17528.5 
* p<0.05, ** p<0.01, *** p<0.001 
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DISCUSSION  
In our study of 421 PLWHA initiating HAART in rural Uganda, we found that the 
trajectories of the PHS and MHS components of HRQOL to be curvilinear and identified 
clinical, economic, and social predictors of HRQOL. Our fully-adjusted quadratic growth models 
showed that both PHS and MHS gradually increased after initiating HAART, peaked at 1.67 
years and 2.18 years after initiation, respectively, and gradually declined. Given that we 
measured HRQOL more frequently (quarterly) and for a longer duration (mean duration of 2.28 
years per patient) than previous studies, this result may explain the inconsistencies among the 
previous studies that showed improvement1,16,25 increase followed by a plateau,2,15,32,33 no 
change,9 or a deterioration in the HRQOL8,34 using less frequent data collection or shorter study 
duration.  
What accounts for the curvilinear relationship between HRQOL and time? There still 
remains a sizable fraction of the variance component within individuals that has not been taken 
into  account  with  the  predictors  in  our  model.  Adaptation  level  theory  suggests  that  people’s  
judgments of wellbeing is subject to the effects of contrast – positive experiences result in an 
upward shift in adaptation level, that experiences thereafter seem less positive – and habituation 
– the effect of positive experiences eventually wear off.55  It is possible that the initial gains in 
HRQOL  experienced  at  the  initiation  of  HAART  increase  PLWHA’s  expectations  of  subjective  
wellbeing, and that the impact of initial gains wear off in time, resulting in an initial increase, 
followed by a plateau and decrease in HRQOL.  
Taking into account that the median survival without HAART once AIDS has developed 
has been reported to be 9.2 months in rural Uganda,56 HAART offers a significant benefit in 
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terms of both survival and HRQOL. Still, we also found clinical, economic, social factors that 
may be targets of interventions to further improve HRQOL. 
 We found that self-reported symptoms were a significant predictor of HRQOL, and 
when added to the model, significantly decreased the magnitude of the relationship between 
HRQOL and TIME and TIME2. Previous studies have found that PLWHA report onset of 
symptoms that are likely adverse effects of HAART, such as diarrhea, nausea, abdominal pain 
and headache,8,57 and these treatment toxicities have been found to be associated with 
deterioration of health-related quality of life.15,58 In our study, CD4 count was not a strong 
predictor of HRQOL, a finding that was also reported by Andrinopoulos and colleagues among 
young women in the US.20 This may be because studies that found significant relationship 
between CD4 cell count and HRQOL used very low cutoffs for CD4 T cell count of 50 to 200 
cells per mm.312,15 
Another factor affecting HRQOL is the persistence of economic and social problems for 
PLWHA in rural Uganda. It is possible that, once PLWHA begin treatment and the survival 
becomes a less immediate concern, the social and economic factors such as obtaining food and 
gaining employment become more salient.59 Food insecurity was negatively associated with both 
PHS and MHS, while unemployment was only associated with MHS, and asset ownership was 
not associated with either HRQOL scores. Food insecurity may be a more sensitive indicator of 
economic wellbeing in resource-poor settings than employment or asset ownership, where many 
people engage in informal economic activities. A qualitative study in Uganda found that after 
being  on  HAART  for  six  months,  PLWHA’s  capacity to engage in work-related activities 
increased substantially, but participants who were salaried employees in the formal labor market 
were unable to resume their former employment after being infected with HIV.3 In our study, 
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such a person may consider him or herself unemployed, but may still contribute to measurably to 
household food intake through informal activities such as tending to their gardens.   
Both enacted stigma and internalized stigma were negatively correlated with PHS and 
MHS scores. This is consistent with previous literature that describes impact of stigma on the 
psychosocial wellbeing of PLWHA, including stress, fear, anxiety, depression, and strained 
relationships with loved ones.26-29 These results show the importance of intervening on the 
economic and social situations of PLWHA in addition to managing their clinical condition.  
We acknowledge several limitations of this study. First, our measures are self-reported 
and therefore suffer challenges generic to all analyses based on self-reported data. Second, it is 
difficult to disentangle the extent to which the estimated associations may simply reflect an 
unmeasured common factor. Our analyses address this issue by using multilevel models that nest 
interviews within individuals. Finally, an individual’s  assessment  of  HRQOL  may  not  be  
reliable, especially among disadvantaged socioeconomic groups. The unequal reliability could be 
because people in less advantaged settings have limited access to education and health facilities 
to accurately perceive their state of health.4 
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CHAPTER 2 
 
The dynamic relationship between social support and HIV stigma among people living with 
HIV/AIDS in rural Uganda 
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INTRODUCTION 
HIV stigma is a well-documented barrier to the health and well-being of people living 
with HIV/AIDS (PLWHA). As described by Goffman, stigma is a discrediting attribute that reduces a person from a whole person to a tainted or discounted person60 and has been associated with delaying or avoidance of HIV testing,61,62 poor adherence to HIV antiretroviral treatment,30 and poor engagement with care.31 In addition, PLWHA 
experience numerous mental and psychological sequelae of stigma, including stress, fear, anxiety, and depression.26-29 
Recent studies have shown that PLWHA who report experiences of stigma also report lower levels of perceived social support.29,63-65 That HIV-related stigma adversely affects the social experience of PLWHA has critical public health implications because social support has powerful health benefits for PLWHA, including less depression, improved coping with their disease, positive health behaviors, and slower progression of disease.21-24 Social support has been found to be beneficial for a wide range of health outcomes, and its health benefits have been attributed to its various functional aspects, including emotional, instrumental, and/or appraisal support.66-68 Through these mechanisms, social support is thought to influence cognitive and emotional states, such as self-esteem and self-efficacy, and promote functional and adaptive coping with stressors. These psychosocial and behavioral benefits translate to health benefits through decreased physiological stress responses, adoption of health-promoting behaviors, and avoidance of health-damaging behaviors.  
Conceptual model 
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Based on evidence that stigma is a multi-dimensional construct, researchers in clinical 
epidemiology have developed and utilized a conceptual model that separates the experience of HIV stigma into interpersonal and intrapersonal experiences. The interpersonal experience of stigma is called enacted stigma and is defined as discriminatory behaviors directed towards people with the stigmatized condition.26 The intrapersonal experience of stigma is called internalized stigma and is defined as the guilt, shame, and self-blame that result when people with the stigmatized condition internalize the beliefs imposed by the majority group.28  
Historically, models of stigma have predominantly focused on the characteristics of individuals - the stigmatized person and the stigmatizing person – and their cognitive, affective and behavioral processes, but recent sociological and anthropological models of stigma have proposed to embed stigma in the social space.69 Of particular importance is 
how  the  effects  of  stigma  extend  to  the  affected  individual’s  close  social  ties,  and  how  social  ties in turn shape their experience of stigma. Qualitative studies have shown stigmatization of family and close friends of PLWHA, termed courtesy stigma, creating a strain in the relationships.  Family members of PLWHA fear discrimination and loss of social standing in the community,70 such that they reluctant to disclose the serostatus of the affected family member to others.26 In addition, close social ties can often be the sources of stigmatizing attitudes and actions. Family and friends become perpetrators of stigma in response to the devalued status they acquire through their association with the stigmatized person,70 and PLWHA experience avoidance, ostracism, and verbal insults from their relatives.26 Furthermore, HIV-related stigma can profoundly limit the ability of PLWHA to seek and 
maintain supportive relationships. Disclosure is essential for people to receive social support; 
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yet, fear of discrimination prevents PLWHA from disclosing their status,71,72 and the higher their 
shame and guilt, the more likely they are to avoid disclosure and interactions with others.28 
Finally, HIV stigma has been correlated with depression,29 which  may  also  limit  PLWHA’s  
capacity for forming and maintaining social relationships.  
 The recent findings linking social support and HIV stigma, though suggestive, were based on cross-sectional data29,63,64 or data from two time points,65 limiting our ability to illuminate the dynamic relationship between social support and HIV-related stigma. Further, these studies have not examined how the interpersonal and intrapersonal dimensions of HIV stigma could differentially affect the social experience of PLWHA. To address these gaps in current understanding of HIV-related stigma and social support, we examined the dynamic relationship between social support and two dimensions of HIV stigma using longitudinal data collected from PLWHA receiving antiretroviral therapy, 
collected over three years at a public hospital in rural Southwest Uganda. The primary aim was to use time-lagged models to understand how the interpersonal and intrapersonal experiences of HIV stigma shape the social support networks of PLWHA, and how these relationships in turn shape the experience of HIV stigma.   
METHODS 
We used data from an ongoing, prospective cohort of PLWHA taking antiretroviral 
therapy (ART) in rural Uganda. Eligibility criteria included having no prior history of treatment 
with HIV ART, being over 18 years of age, and living within 20 km of the Immune Suppression 
Syndrome (ISS) Clinic at the Mbarara Regional Referral Hospital. The ISS Clinic is located in 
Mbarara District, 275 km southwest of Kampala, and provides free ART for people living with 
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HIV/AIDS in southwestern Uganda, Rwanda and the Democratic Republic of Congo.36 The 
majority of the population in Mbarara district is ethnically Ankole, and the local language is 
Runyankole. The local economy is largely based on subsistence agriculture.  
Our analyses are based on data from participants who were enrolled into the cohort from 
2007 through 2010. Survey questions were translated into Runyankole, back-translated into 
English, further modified through focus groups with key informants, and pilot-tested to ensure 
clarity and relevance. Trained research assistants who spoke Runyankole interviewed 
participants every three months in a private room at the site research office near the ISS Clinic. 
Each survey took approximately one hour to complete.  
Informed consent was obtained from all study participants. Ethical approval for all study 
procedures was obtained by the Committee on Human Research, University of California at San 
Francisco; the Partners Human Research Committee at Massachusetts General Hospital; and the 
Institutional Ethical Review Committee, Mbarara University of Science and Technology.   
 The three variables of interest were social support, internalized stigma, and enacted stigma. These variables were assessed at baseline and at each quarterly follow-up interview using the scales described below. We measured social support using the Social Support Scale,48 which contains 10 items about instrumental and emotional social support. High scores reflect higher levels of social support. This scale is adapted from the Duke-University of North Carolina Functional Social Support Questionnaire, which was designed to measure multiple dimensions of social support among patients in a primary care setting.49  
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We measured internalized HIV stigma using the Internalized AIDS-Related Stigma Scale, which contains six items corresponding to the guilt, shame, and worthlessness in 
Goffman’s  conceptualization  of  stigma.50,51 To measure enacted stigma, we asked participants about whether they had experienced 10 discriminatory events in the past three months as a result of their HIV status, such as abandonment, housing, or property loss, or physical violence.53 The enacted stigma scale was calculated as the sum of the 10 items, with higher scores indicating greater intensity of enacted stigma experienced. 
 In our regression models, we adjusted for baseline and quarterly health status using CD4+ T-lymphocyte cell count and physical health-related quality of life, which we measured with the Medical Outcome Study-HIV (MOS-HIV) Physical Health Summary (PHS).37,38 A higher score reflects a better health-related quality of life. Because prior studies have shown that both HIV stigma and low social support are associated with depression,27,29 we also adjusted for depression symptom severity. We measured depression using a version of the 15-item Hopkins Symptom Checklist for Depression42 that was adapted to the local context with the addition of a 16th item,  “feeling  like  I  don’t  
care  about  my  health.”  27,43 We restricted our calculation of the score to the 12 affective items in light of prior research suggesting that the somatic items overlap with symptoms of HIV infection and may inflate the prevalence of depression among PLWHA.44,45 Participants were classified as having probable depression based on the conventional threshold score of 1.75.46  
 We adjusted for a range of other baseline (time-invariant) demographic and socioeconomic covariates with potential for influencing the relationships among stigma, 
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social support, and health. We measured household wealth using a household asset index,47 which was entered into the models as a continuous variable, with higher values of the asset index indicating greater household wealth relative to other households in the sample. We also adjusted for baseline age, sex, educational attainment and marital status. Time was measured in years since starting ART.  
Data analysis was conducted using SAS statistical software (version 9.2, SAS Institute Inc., Cary, North Carolina). We employed multilevel modeling to address the lack of independence among residuals in hierarchically structured data. Since our data consisted of measures that are nested within individuals, measures from the same individual may share common, unobserved characteristics that may affect the outcomes of interest. Our modeling technique allowed us to separate the composite residual into two parts: a measure-level residual unique to the particular time at which the survey was conducted, and an individual-level residual unique to a particular individual (but not to a particular time). We used multilevel models for change, in which the models are specified by simultaneously postulating a pair of subsidiary models: a level-1 submodel that describes how each individual changes over time, and a level-2 submodel that describes how these changes differ across individuals.54 Our level-1 submodel stipulated that the trajectories of stigma and social support are linear with time.  
To investigate the dynamic relationships between social support and HIV-related stigma, we estimated both contemporaneous and lagged-covariate multilevel models for change. The first contemporaneous model specified internalized stigma as the outcome and the second specified enacted stigma as the outcome. Both included social support 
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measured at the same time as the main predictor. We decided that contemporaneous models for social support would be redundant to our analysis because they would show similar relationships between social support and stigma.  
 In lagged-covariate models, the predictor of interest was lagged by three months. The first model specified internalized stigma as the outcome and lagged social support as the main predictor, while also adjusting for lagged internalized stigma in addition to the other covariates as described above. The second model specified enacted stigma as the outcome and lagged social support as the main predictor, while also adjusting for lagged enacted stigma and the other covariates. In the next set of models, lagged internalized (or enacted) stigma was the main predictor, social support was the outcome, and we also adjusted for lagged social support and the other covariates. In sum, we fit six multilevel regression models for change.  
Preliminary analyses supported the use of multilevel models for change and lagged models. Briefly, empirical growth plots showed substantive changes within individuals over time in enacted stigma, internalized stigma, and social support. Further, intraclass correlation indicated large variability within individuals over time. Intraclass correlation for social support was 0.30, indicating that an estimated 30% of the total variation in social support is attributable to differences between individuals while 70% is attributable to variability within individuals. Likewise, the intraclass correlations for internalized stigma and enacted stigma were 0.46 and 0.27, respectively. 
RESULTS 
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 Table 1 presents the baseline demographic characteristics of the 413 participants. The 
average age at baseline was 35 years, and they were enrolled in the study for a median of 2.09 
years. The majority of participants (324 [71%]) were female. Approximately half were married 
and half were widowed or divorced. The majority (246 [60%]) had completed primary school, 
and 97 (23%) completed secondary school or more. The median internalized stigma score was 0 
points (Q1– Q3 = 0 – 2.00, mean=1.05), the median enacted stigma score was 0 points 
(IQR=1.00, mean=0.38), and the median social support score was 4.00 points (IQR=0.40, 
mean=3.74) points at baseline. The median CD4 count at baseline was 263 cells/mL (IQR = 
176).  Approximately 7% of participants were depressed at baseline.  
Table 2.1 Participant Baseline Characteristics (N=413) 
Characteristic  N (%), median (Q1-Q3) 
Gender   
 Female 293 (71%) 
 Male 120 (29%) 
Age at start of study  35.00 years (30.00-40.09) 
Time in study  2.09 years (1.72-2.78) 
Marital status   
 Not married 30 (7%) 
 Married 187 (45%) 
 Separated/widowed/divorced 196 (47%) 
Education   
 None 70 (17%) 
 Primary 246 (60%) 
 Secondary and more 97 (23%) 
Internalized stigma 6-item scale 0 (0-2) 
Enacted stigma 10-item scale 0 (0-1) 
Social support 4-point scale 4.0 (3.6-4.0) 
CD4 count  263 cells/mL (176-352) 
Physical health MOS-HIV 52.25 (44.83-57.26) 
Depression  30 (7%)  
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Internalized stigma 
We found that social support and internalized stigma measured at the same time-point were negatively correlated (Table 2). On average, individuals who reported higher levels of perceived social support reported lower levels of internalized stigma. Each one-point increase in the social support scale was associated with a 0.28-point decrease in the internalized stigma scale (95% CI, -0.51 to -0.041). Other factors associated with internalized stigma include self-reported physical health, depression, and educational attainment. In the lagged-covariate model, social support was not associated with subsequent internalized stigma (b= -0.012; 95% CI, -0.14 to 0.11).  
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Table 2.2 The Effect of Contemporaneous Social Support and Lagged Social 
Support on Internalized Stigma 
  Contemporaneous Lagged 
Fixed effects  b (95% confidence 
interval [CI]) 
b (95% CI) 
Intercept  1.62 (0.66, 2.58)* 0.57 (-0.038, 1.18) 
Social support  -0.28 (-0.51, -0.041)* ----- 
Lagged social support  ---- -0.012 (-0.14, 0.11) 
Lagged internalized 
stigma 
 ---- 0.12 (0.086, 0.16)*** 
Time  Years -0.39 (-0.85, 0.066) -0.0071 (-0.081, 0.067) 
Time*social support  0.10 (-0.023, 0.22) ----- 
Gender  Male 
Female 
 
0.15 (-0.12, 0.42) 
 
0.13 (-0.11, 0.38) 
Age Centered -0.0073 (-0.022, 0.0076) -0.0062 (-0.019, 0.0071) 
Marital status Married 
Separated 
Single 
 
-0.049 (-0.24, 0.15) 
0.17 (-0.12, 0.51) 
 
-0.044 (-0.23, 0.14) 
0.14 (-0.25, 0.53) 
Education No school 
Primary school  
Secondary school 
 
0.19 (-0.12, 0.51) 
0.42 (0.045, 0.80)* 
 
0.20 (-0.078, 0.47)  
0.40 (0.066, 0.73)* 
Wealth Asset index 
quintile 
0.026 (-0.84, 0.89) 0.0084 (-0.069, 0.085) 
Physical health MOS-HIV, 
centered 
-0.015 (-0.022, -
0.0079)*** 
-0.015 (-0.022, -
0.0079)*** 
CD4 x 100 cells /mL 0.0044 (-0.032, 0.041) 0.0019 (-0.034, 0.038) 
Depression  0.37 (0.13, 0.61)** 0.43 (0.18, 0.67)*** 
Variance components   
Level-1: within person 0.97 (0.31, 1.63)*** 1.03 (0.96, 1.10)*** 
Level-2: in intercept 1.00 (-0.95, 2.96)*** 0.81 (0.63, 0.99)*** 
Level-2: rate of change 0.041 (-0.0061, 0.89)* 0 
Goodness-of-fit   
-2LL 7288.3 7271.5 
***P < 0.001, **P<0.01, *P<0.05 
 
Enacted stigma  We found that social support and enacted stigma measured at the same time-point were negatively correlated (Table 3). On average, individuals who reported higher levels of perceived social support reported lower levels of enacted stigma. Adjusting for sociodemographic and health characteristics, a one-point increase in the social support 
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scale was associated with a 0.18-point decrease in the enacted stigma scale (95% CI, -0.31 to -0.046). Self-reported physical health, wealth, marital separation, and educational attainment were also associated with enacted stigma. In the lagged covariate models, we found that enacted stigma was negatively correlated with lagged social support (Table 3). A one-point increase in the lagged social support score was associated with 0.16-point decrease in enacted stigma score, controlling for lagged social support and sociodemographic and health characteristics (95% CI, -0.24 to -0.090). 
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Table 2.3 The Effect of Contemporaneous Social Support and Lagged Social 
Support on Enacted Stigma.  
  Contemporaneous  Lagged  
Fixed effects  b (95% CI) b (95% CI) 
Intercept  1.21 (0.69, 1.72)*** 1.08 (0.77, 1.39)*** 
Social support  -0.18 (-0.31, -0.046)** ----- 
Lagged social 
support 
 ----- -0.16 (-0.24, -0.090)*** 
Lagged enacted 
stigma  
----- 0.075 (0.035, 0.12)*** 
Time years 0.24 (-0.020, 0.50) 0.0058 (-0.033, 0.045) 
Time*soc support  -0.070 (-0.14, 0.00081) ----- 
Gender  
 
Male 
Female 
 
0.077 (-0.022, 0.17) 
 
0.085 (-0.0033, 0.0070) 
Age Centered 0.0014 (-0.004, 0.0069) 0.0018 (-0.0033, 0.0070) 
Marital status 
 
 
Married 
Separated 
Single 
 
0.090 (0.0062, 0.17)* 
-0.074 (-0.24, 0.090) 
 
0.085 (0.0040, 0.17)* 
-0.074 (-0.23, 0.081) 
Education No school 
Primary school 
Secondary 
school 
 
-0.14 (-0.25, -0.024)* 
-0.099 (-0.24, 0.037) 
 
-0.13 (-0.23, -0.022)* 
-0.099 (-1.39, 1.19) 
Wealth Asset index 
quintile 
-0.039 (-0.071, -0.0075)* -0.044 (-0.074, -0.014)** 
Physical health MOS-HIV, 
centered 
-0.0090 (-0.013, -
0.0051)*** 
-0.0090 (-0.013, -
0.0052)*** 
CD4 x 100 cells /mL 0.0012 (-0.018, 0.020) 0.0041 (-0.014, 0.023) 
Depression  0.14 (0.033, 0.24) 0.14 (-0.0013, 0.27) 
Variance components   
Level-1: within person 0.37 (0.35, 0.40)*** 0.39 (0.36, 0.42)*** 
Level-2: in intercept 0.084 (0.054, 0.11)*** 0.067 (0.038, 0.096)*** 
Level-2: rate of change 0.0045 (-0.0037, 0.013) 0.0041 (-0.0034, 0.012) 
Goodness-of-fit   
 -2LL 4626.8 4754.9 
***P < 0.001, **P<0.01, *P<0.05 
 
Social Support 
We employed lagged multilevel models for change to examine determinants of social support. Social support was associated with both lagged internalized stigma as well as enacted stigma (Table 4). A one-point increase in lagged internalized stigma was associated with a 0.015-point decrease in social support (95% CI, -0.027 to -0.0028). 
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Similarly, a one-point increase in lagged enacted stigma was associated with a 0.035-point decrease in social support (95% CI, -0.058 to -0.013).  
Table 2.4 The Effect of Lagged Internalized Stigma and Lagged Enacted Stigma 
on Social Support.  
  Lagged int stigma 
model 
Lagged enacted stigma 
model 
  b (95% CI) b (95% CI) 
Fixed effects    
Intercept   3.10 (2.93, 3.28)*** 3.1261 (2.95, 3.30)*** 
Lagged internalized 
stigma 
 -0.015 (-0.027, -
0.0028)* 
----- 
Lagged enacted 
stigma 
 ----- -0.035 (-0.058, -0.013)** 
Lagged social 
support 
 0.16 (0.12, 0.20)*** 0.15 (0.11, 0.19)*** 
Time Years -0.054 (-0.076, -
0.031)*** 
-0.049 (-0.071, -0.027)*** 
Gender Male 
Female 
 
-0.087 (-0.14, -
0.032)** 
 
-0.085 (-0.14, -0.032)** 
Age-35 Centered -0.00048 (-0.0035, 
0.0026) 
-0.00024 (-0.0032, 
0.0027) 
Marital Status Married 
Separated 
Single 
 
0.021 (-0.026, 0.068) 
0.062 (-0.029, 0.15) 
 
0.020 (-0.036) 
0.059 (0.15) 
Education No school 
Primary school 
Secondary 
school 
 
0.035 (-0.027, 0.097) 
0.064 (-0.012, 0.14) 
 
0.032 (-0.029, 0.0927) 
0.060 (-0.014, 0.13) 
Wealth Asset index 
quintile 
0.051 (0.034, 
0.069)*** 
0.048 (0.031, 0.066)*** 
Phs-50 HIV-MOS, 
centered 
0.0039 (0.0017, 
0.0061)*** 
0.0037 (0.0016, 
0.0058)*** 
CD4 x 100 cells /mL -0.022 (-0.033, -
0.011) *** 
-0.021 (-0.031, -0.011)*** 
Depression  -0.081 (-0.16, -
0.0023)* 
-0.063 (-0.14, 0.014) 
Variance components   
Level-1: within person 0.12 (0.11, 0.13)*** 0.12 (0.11, 0.13)*** 
Level-2: in intercept 0.025 (0.014, 
0.035)*** 
0.024 (0.014, 0.035)*** 
Level-2: rate of change 0.0014 (-0.00091, 
0.0037) 
0.00095 (-0.0011, 0.0030) 
Goodness-of-fit    
-2LL  2030.4 2055.3 
***P < 0.001, **P<0.01, *P<0.05 
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DISCUSSION 
In this longitudinal analysis of data from PLWHA initiating ART in rural Uganda, we found evidence that both internalized and enacted stigma may compromise the ability to maintain and access support from friends and family. At the same time, we found that social support was protective against future experiences of enacted stigma but not against internalized stigma. The estimated associations were strong, large in magnitude, and robust to lagged specifications.  
In this study, we found a dynamic relationship between enacted stigma and social support. When social support was lagged by one quarter, it had a statistically significant, and inverse association with enacted stigma. Similarly, when enacted stigma was lagged by one quarter, it retained a statistically significant association with subsequent social support. Our findings suggest that PLWHA who report experiences of discrimination are more likely to lose their social support, consistent with the idea that friends and family members, who provide the bulk of social support, are also the sources of discrimination, prejudice, avoidance and abandonment. These findings also suggest that discrimination towards PLWHA negatively affects their friends and family by association. Goffman 
described  the  process  of  “courtesy  stigma,”  in  which  people  who  are  “related  through  the  social  
structure  to  a  stigmatized  individual…are  all  obliged  to  share  some  of  the  discredit  of  the  
stigmatized  person.”60 Goffman further  states  that  courtesy  stigma  “provides  a  reason  why  such  
relations  tend  either  to  be  avoided  or  to  be  terminated.”60 More recently, Yang and colleagues proposed that stigma threatens interpersonal relationships of affected individuals by threatening the moral standing of their family and other members of their social network, 
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and this leads them to discriminate against the stigmatized person.70 As an example, they 
present  a  study  of  mental  illness  in  Hong  Kong  that  found  that  family  members’  fear  of  social contamination and loss of face motivated them to discriminate against and abandon their ill family member.  
We found that internalized stigma and social support were negatively correlated with one another, consistent with previous research.29,63,65 When internalized stigma was lagged by one quarter, it had a statistically significant, and inverse association with social support. This result suggests that PLWHA who experience more shame and guilt about HIV are less able to have supportive relationships with friends and family. This may be because people who report high levels of internalized stigma are less likely to disclose their HIV status to their friends and family or to solicit support from them.29 Internalized stigma has also been found to correlate with depression,27,29 which could also compromise affected 
persons’  ability  to  seek  and  maintain  supportive  relationships.  Further,  caring  for  PLWHA  exerts substantive physical and psychological burdens on caregivers, especially in the setting of depression.73 This  could  result  in  a  negative  “feedback  loop”  of  social  support,74 in which the strain of supporting a person with a serious illness results in network members withdrawing and severing the relationship in order to cope with the strain.  
How can we understand why people living with HIV who report high levels of perceived social support subsequently report low levels of enacted stigma, but not internalized stigma? Having the support of friends and family can protect the person from becoming targets of external, visible acts of discrimination and insults. However, such supportive relationships may not be as instrumental in protecting the individual from their 
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own beliefs of guilt, immorality, and dirtiness for being infected with HIV. We hypothesize that internalized stigma is determined by a complex set of individual factors such as perception of the legitimacy of stigma and personal identification with the larger group of individuals with the same condition.75,76  
 Our findings suggest that people living with HIV/AIDS who are most affected by HIV 
stigma may suffer the additional burden of losing social support. The emotional, material, and appraisal resources provided by social support are critical for people living with HIV in resource-poor settings like Uganda, who must address day-to-day economic challenges while adhering to ART, maintaining positive health behaviors, and coping with the burden of illness and stigma. In one qualitative study of 252 PLWHA in three sub-Saharan African settings, social relationships were found to maintain ART adherence not only by providing of money for transport to clinic, encouragement, and regular reminders, but also by presenting a social expectation of adherence that created obligations on the part of the patients to adhere.77  
We acknowledge several limitations of this study. First, our measures are self-reported and therefore suffer challenges generic to all analyses based on self-reported data. Second, it is difficult to disentangle the extent to which the estimated associations may simply reflect an unmeasured common factor. Our analyses address this issue by using multilevel models that nest interviews within individuals. Furthermore, the lagged models examine determinants of stigma or social support after adjusting for lagged values of the variables. Related to this limitation, the perception of social support may not correlate perfectly with the actual degree of social support received. However, prior studies have 
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demonstrated that perceived social support is more predictive of health outcomes than actual social support for people living with HIV/AIDS.22 Second, our study sample consisted of people living with HIV/AIDS who were initiating ART. As stigma is a significant barrier for patients to access and adhere to treatment, 78-81 and access to treatment has been shown to lower stigma,82,83 it is likely that overall levels of internalized stigma were lower in our sample compared to untreated PLWHA. Because social support is also known to be positively associated with treatment access,77 this could have biased our estimates away from the null.  
In summary, we found that both internalized and enacted stigma may compromise the ability of PLWHA to maintain and access support from close social ties and that social support may be protective against future experiences of discrimination. While many strategies for stigma reduction have been proposed,75 research that rigorously evaluates interventions on HIV stigma is limited,84 and those that do often fail to demonstrate enduring effects on stigma.85 Taken together, our findings about the bidirectional relationships between stigma and social support further emphasize the importance of research on interventions that address HIV stigma, which will not only decrease the burden of stigma but also strengthen social support that is an invaluable resource for people living with HIV/AIDS.  
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CHAPTER 3 
 
Interdisciplinary review of health-related stigma   
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INTRODUCTION  
Across time periods and cultures, people have held negative attitudes towards certain 
health conditions, discriminating against individuals with conditions such as obesity, smoking, 
mental illness, HIV/AIDS, and cancer. Sociologist Goffman described this negative and 
discriminatory attitude as stigma - the devaluation of an individual based on some characteristic 
they possess, such that the person is believed to be not quite human.60 Since  Goffman’s 
benchmark social theory of stigma, social scientists have offered theories regarding the causes, 
processes, and outcomes of health-related stigma through a variety of disciplinary methods and 
theoretical frameworks, situating stigma in individual, interpersonal, social, and political spaces. 
Health and social policies have used health-related stigma, implicitly or explicitly to 
discourage from engaging in unhealthy behaviors for the goal of improving the health of the 
population. One salient instance is the British public  health  minister’s recommendation that 
health  professionals  use  the  term  “fat”  instead  of  “obese”  to  encourage  “personal  responsibility”  
on the part of obese people, which received criticism by health experts that such a 
recommendation could stigmatize those who are overweight.86,87 However, stigma has been 
associated with various negative clinical outcomes, including poor adherence to treatment,30 poor 
engagement with care,31 and delayed care-seeking.61 Furthermore, targets of stigmatization have 
reported numerous mental and psychosocial sequelae of stigma, including fear, isolation, 
anxiety, depression, and poor psychological functioning. Should stigma be utilized as a tool to 
promote public health, or should societal efforts focus on eliminating health-related stigma? In 
order to address this question, I examine the underlying tension in the stigma literature regarding 
the origin of stigma. Scholars predominantly in social and evolutionary psychology 
conceptualize stigma as a product of individual cognitive patterns that evolved as a basic need 
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for survival, while those in sociology, history, and anthropology conceptualize stigma as a 
product of social forces rooted in economic and political power differentials that serve to 
perpetuate and legitimize those injustices. Also central to this discussion – whether stigma can 
and should be used to promote health – is how the changing notions of who (or what) is 
responsible for making an individual sick has contributed to the stigmatization of certain health 
conditions.   
The goal of this paper is to explore the scholarly theories on health-related stigma, 
analyze their contributions to the debate on the causes of health-related stigma. While theories 
within a discipline offer often-debated explanations of the same reality, theories from different 
disciplines diverge more widely because of their focus on distinct aspects of the shared referent 
reality.88 The individual and interpersonal theories of stigma suggest that stigma is based in the 
realm of private encounters between two people who possess certain physical and personality 
traits. In contrast, the conceptualizations of health-related stigma in history, anthropology, and 
autobiography incorporate the social forces outside of the individual as playing a central role in 
the production of stigma. I show that policies that stigmatize health behaviors and health 
conditions have not been shown to be effective in promoting health, especially among those who 
are the targets of stigma. Moreover, these health policies harm the stigmatized individuals 
through humiliation and shame and by limiting their access to health and societal resources. I 
argue that policies that promote or condone the use of health-related stigma ultimately 
exacerbate the social and economic disparities that underlie stigmatization, which further leads to 
stigmatized health behaviors and outcomes. 
INDIVIDUAL AND INTERPERSONAL THEORIES 
Social psychology of stigma   
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Traditionally, social psychologists have examined the cognitive, affective, and behavioral 
reactions of persons who interact with stigmatized individuals to understand the individual and 
interpersonal production of stigma. I focus here on the literature on characteristics of the 
stigmatized trait and the stigmatizer that determine the nature and extent of the stigma.  
Social psychologists have identified a set of core psychological interpersonal responses to 
deviance across a variety of individual and group stigmas. First, a trait that sets a person apart 
from others is identified. Second, once a person is labeled as deviant, this person is linked to 
undesirable characteristics based on dominant cultural beliefs.89 These perceptions then induce 
others to systematically alter their expectations and responses when they interact with the labeled 
person. Labeling theory further asserts that the labeled person incorporates others’  expectations  
into his or her own self-concept, thereby taking on a role identity consistent with the label.90,91 
Only certain types of traits are likely to be viewed as relevant and consequential to 
stigmatized conditions, thereby becoming the source of the stigmatizing label. Goffman initially 
described three groups of characteristics that are likely to receive stigmatization: physical 
deformities, blemishes of character, and “tribal”  characteristics of race, nationality, and 
religion.60 Although  Goffman’s  formulation  is  not  specific  to  health-related stigma, these 
categories can be readily applied to health conditions. For example, obese individuals may be 
perceived as possessing a physical deformity and/or manifesting a blemish of character  (e.g., 
lack of motivation).91 Jones and colleagues add granularity to these stigmatizing characteristics 
by proposing further dimensions to consider: the concealability of the trait, the course of the trait 
over time, the disruptiveness of the trait during social interactions, the aesthetic quality of the 
trait, the origin of the trait, and the danger posed by interacting with a person who possesses the 
trait.89 For example, individuals in many societies believe that people with mental illnesses are 
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chronically affected, demonstrate non-normative behavior that it is disruptive to social 
encounters, have an unaesthetic, disheveled appearance, and have a tendency towards violent 
behavior. These beliefs contribute to the stigmatization of mental illness.91 However, a disease 
does not necessarily need to fulfill many of these characteristics to be stigmatized: the sheer fear 
propagated by the media that Severe Acute Respiratory Syndrome (SARS) would propagate 
uncontrollably, overwhelm public health resources, create global economic disasters, and kill 
millions of people lead to the stigmatization of people infected with SARS.92 
While the aforementioned traits and characteristics may identify individuals as deviant, a 
core factor that translates this identification into stigmatization is attribution, or the notion that an 
individual is responsible for his or her health condition. Hinshaw suggests that mental illness is 
often viewed as the product of weak will or other controllable causes.91 HIV/AIDS is often 
associated with marginalized behaviors such as sex work, drug use, and homosexual practices.84 
Through social psychology experiments that manipulate the perceiver’s  understanding  of  
attribution, researchers have found evidence largely supporting this relationship between 
attribution and stigma. Several interventions that highlight external, uncontrollable causes of 
obesity improved attitudes towards obese individuals, while others were less conclusive.93 As I 
will discuss later, these assumptions about the causes of health conditions is based on a 
reductionist understanding of personal agency and health.  
Social psychologists have also explored the motivation of the stigmatizer to stigmatize. 
Crandall and Cohen compiled a cluster of personality traits that commonly manifest in people 
who are more likely to reject a range of stigmatized groups, such as people who are obese, 
people with schizophrenia, and people with HIV/AIDS. People who stigmatized were found to 
have the following personality traits in common: included loneliness, alienation, having little 
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faith in people, submission to traditional authority, and a belief that people get what they earned 
in life.94,95 Others have proposed that the act of stigmatizing has functional value for the 
stigmatizer, given the ubiquitous presence of stigma in a variety of social contexts.91,96 
Specifically, the stigmatization of an out-group helps delineate the distinction between self and 
others, promoting social identity. Stigmatization of others may also enhance  one’s  own  self-
esteem by justifying a social structure in which the stigmatizer has privilege over the 
stigmatized. Furthermore, by rejecting those who deviate from social norms, stigmatization may 
allow the stigmatizer to validate his or her values and behaviors, and avoid the anxiety of having 
those values challenged.96 Finally, fostering a sense of empathy towards the stigmatized 
individual may lead the stigmatizer to adopt the perspective of the individual, value his or her 
wellbeing, and soften the feelings of stigma. By experimentally manipulating the  participant’s  
empathy towards stigmatized populations, Batson and colleagues found that they could induce 
enduring positive attitudes towards people with HIV, homeless persons, and convicted 
murderers.97 
Evolutionary theories of stigma 
 Evolutionary theories of stigma offer a different perspective on stigmatized traits and the 
motivations behind stigmatization by arguing that the human disposition to stigmatize is rooted a 
biological instinct to avoid dangerous infectious pathogens. Disgust, one of the main emotional 
characteristics associated with stigma, is believed to have evolutionary origins. Disgust is 
typically experienced as a feeling of revulsion, sometimes accompanied by nausea, along with a 
strong desire to withdraw from the eliciting stimulus. Rozin and Haidt argue that the emotion of 
disgust originated as a rejection response designed to avoid ingestion of dangerous foods.98 
Schaller and colleagues argue more broadly that, because signs of disease consistently elicit 
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disgust, disgust evolved as a response to infectious agents. They call this particular response the 
“behavioral  immune  system,”  and  hypothesize  that  it operates through the detection of visual 
morphological abnormalities in others that signal potential disease.99 A similar set of disease-
predictive cues has been shown to elicit disgust across numerous cultures.100 For example, Curtis 
and colleagues found that disease-relevant images significantly elicited more responses of 
disgust than similar images with little or no disease relevance across nine different cultural 
regions.101  
As with disgust toward disease, disgust toward moral offenses has been found across 
cultures, and how disgust has evolved to respond to a wider range of non-infectious offenses is 
debated. Oaten and colleagues argue that the moral dimension of disgust is elicited towards 
activities and behaviors that were originally a means of managing disease-related threats.100 
Disease-avoidant psychological responses may be related to avoiding encounters with foreign 
people; and indeed, Schaller, Murray, and Damian found that people who live in regions of the 
world with higher prevalence of infectious diseases are less open to new experiences and 
unrestricted sociosexuality.102 An alternative hypothesis is that the disgust response has evolved 
to be oversensitive, and is more likely to reject healthy individuals rather than accept potentially 
harmful individuals, as this would be more adaptive. Taken together with the belief that the 
response is activated through automatic, non-cognitive pathways to allow for rapid withdrawal 
from pathogenic cues,100 the behavioral immune response responds to seemingly irrational cues 
that pose little danger, such as obese individuals and people with cancer. Some evidence suggests 
the continuity between disease-related disgust elicitors and non-infectious cues. For example, 
fear of infection is activated when people show disgust toward people with non-infectious 
conditions. Park and colleagues found that negative feelings toward obese people were 
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associated with fear of infection, as study participants associated obesity with disease-relevant 
concepts, and participants who felt more vulnerable to disease were more likely to show 
antipathy toward obese people.99 
Finally, some proponents of the evolutionary theory argue that the ubiquitous human 
practice of stigmatizing others is rooted primarily in the biologically based need to live in 
effective groups.103 Kurzban and Leary argue that stigma has evolved as a functional adaptation 
to avoid associating with those who present any form of evolutionary disadvantage.104 This 
theory aims to explain the evolutionary basis of stigmatizing people who serve as poor partners 
of social exchange, such as people who have little to offer in terms of social gain or show 
unpredictable behaviors.  
In summary, the individual and interpersonal theories of stigma do not offer a strong 
support for society to intervene to alleviate stigmatizing attitudes. The evolutionary theories of 
stigma suggest that stigmatization may be an automatic response that is ingrained in the human 
biology. Further, the assertion that stigmatization evolved as a response to avoid people who are 
infectious or otherwise pose an evolutionary disadvantage implies that stigmatization is (or has 
been in the past) a beneficial process that serves to maximize fitness. In the following sections, I 
discuss the conceptualizations of health-related stigma found in history, anthropology, and 
autobiography, which shed a different light on health-related stigma by pointing to the social 
forces outside of the individual as playing a central role in the production of stigma. These show 
that health-related stigma is a dehumanizing process based on socially constructed ideas about 
disease causality, that has been used to denigrate those who are on the lower rungs on the ladder 
of society, and that continues to perpetuates these disparities by limiting access to societal 
resources.  
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SOCIAL THEORIES OF STIGMA 
Stigma and the social construction of disease causations 
The literature on the history of medicine illustrates that evolving understandings about 
how and why people become sick reflected contemporary social values. These understandings of 
disease causation lead to the creation of meanings associated with these sicknesses. Leprosy and 
epilepsy were both believed to be the embodiment of immoral forces outside of the domain of 
health, whether divine retribution for wrongdoings and character flaws, or possession by the 
demonic forces. These etiologic understandings shaped the societal responses to mental illness 
and leprosy, both of which were believed to be contagious because moral failings and possession 
were seen as contagious.  
In China, leprosy was among the many serious ailments, particularly those with 
conspicuous and unappealing external symptoms on the skin, believed to be retributions for 
unrepented wrongdoings of the victim or of their ancestors.105 This belief was reflected in the 
societal response to people with leprosy, who were targets of numerous forms of structural 
discrimination, condemned and cursed by the law and in various religious traditions across time. 
People with leprosy in early imperialist China  had  “unusual  legal  status.”105 For example, in the 
Qin statues, a patient with leprosy was deprived of the right to marriage. Further, forms of capital 
punishment for leprosy criminals were imbued with ritual meanings: people with leprosy were 
drowned in still water or buried alive, which reflected society’s  attempts  to  ward off the 
supernatural threats that leprosy patients were considered to personify. Even after such extreme 
legal practices were discontinued, isolation and segregation of leprosy patients continued. At the 
same time, while the presumed etiology of leprosy invited harsh legal and religious treatment, it 
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also invited attempts to cure the disease by restoring the morality of the sufferers.105 Stories in 
the Buddhist tradition depict miraculous healings of leprosy patients by morally superior men 
through show of faith, charity, and sacrifice, while the Daoist tradition approached healing 
leprosy through bodily self-cultivation, moral discipline, and disdain for worldly comfort.  
Similarly, the epileptic was believed to signify possession by gods and demons during the 
ancient times, and people feared that whoever touched the epileptic might become prey to the 
demon.106 Because of its physical and psychic symptoms, magical and natural explanations for 
epilepsy coexisted during the end of the fifteenth century. Some physicians blamed possession, 
magic, and witchcraft, some subscribed to a purely medical understanding of epilepsy, and others 
espoused a kind of merger of the two theories: the demonic acts were an external trigger that set 
the inner, physiological causes in motion.106  
The interest in personal responsibility for health emerged far before biomedical 
understandings of disease elucidated the mechanisms through which health behaviors could 
promote or endanger health. During the Enlightenment, early statistical studies attempting to 
identify behavioral causes of epilepsy concluded that fearfulness, masturbation, and drunkenness 
were among the most frequent causes of epilepsy among their patients.106 Seventeenth- and 
eighteenth-century guides for health emphasized the need for individuals to control all aspects of 
life as much as possible: their diet, exercise, sleep, evacuations, and emotion.107 The 
predisposition to both acute and chronic diseases was understood as a cumulative effect of 
constitution, circumstance, and regimen, and the individual was responsible for acquiring the 
illness in addition to recovering from it.  
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The introduction of germ theory led to the belief that disease was a result of the chance 
encounter between the individual and causal agent, and hence placed emphasis on the existence 
of discrete, external causes.107 However, as chronic diseases increased in the 20th century, 
emphasis was again placed on the notion of individual choice and individual responsibility. 
Epidemiologic studies in the first half of the twentieth century identified specific behaviors such 
as smoking,  diet,  and  exercise,  and  offered  the  possibility  of  control  over  one’s  health.108 This 
lead to the renewed emphasis on individual responsibility for health; as Rosenberg states 
“chronic illness becomes in this moral sense an aggregate of cigarettes smoked, seatbelts 
unfastened, glasses filled and emptied, cheeseburgers devoured.”107 During this time, smoking, 
sexually transmitted diseases, obesity, and cancer acquired stigmatized status because of the 
notion of personal agency that accompanied them.  
More recently, Gilman proposed that obesity simultaneously evokes both the personal 
responsibility and infectious disease models of disease. He asserts that, rather than the adverse 
health consequences of excess weight, the belief that excess weight signifies lack of will that has 
caused a “moral  panic.”109 Thus, dieting has become the means of self-liberation by which the 
individual reasserts control over his or her body. At the same time, obesity is also understood as 
if it were infectious.109 He demonstrates this using two illustrations: first, the popularity of the 
term  “obesity  epidemic”  connotes excess weight as if it were spreading uncontrollably in the 
community; second, society views excess weight as if it were monocausal, and hence look for a 
single magic bullet to offer a quick fix to the disease. The blaming of single food items as 
responsible for obesity (e.g. saturated fats, high fructose corn syrup, and fast food) and the 
flooding of diet foods onto the market both signify this belief.  
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Sontag criticizes society’s  denial  of death and belief that medicine should cure all illness 
for the creation of health-related stigma. She argues that conditions that are not curable attain a 
special status and are treated with mystery and fear.110 Further, because death has come to be 
understood  as  an  “offensively  meaningless  event,”  diseases  that  are  equated  with  death  are  
extremely feared and concealed from loved ones, and at times from the patients themselves in the 
case of cancer.110 In addition, the fear of moral contagion makes friends and family shun people 
with cancer.110 
These  examples  resonate  with  Brandt’s assertion that the  “perceptions  about  what  causes  
disease…reflect powerful moral beliefs,” and that these beliefs in turn shape the social response 
to the disease.108 Supernatural forces, moral and infectious contagion, lack of self-discipline and 
self-restraint, and death were concerns that loomed large in each of the time periods, and the 
stigmatization of leprosy, epilepsy, and obesity can be explained by these fears. It is now known 
that these many chronic and acute health states have complex causal frameworks. While high 
levels  of  stigmatizing  attitudes  are  correlated  with  the  belief  that  smoking  is  cased  by  “weak  
character,”111 smoking is increasingly understood to be a complex behavior that is shaped by 
deep social, cultural, and economic forces, as well as the biological process of addiction.112 Even 
the tobacco industry has been implicated in engaging in innovative advertising, marketing, and 
manipulating scientific debates to engineer a culture in which smoking is mainstream and 
universal.113 More generally, a strong association between socioeconomic status and health has 
been consistently shown across health conditions, prompting Link and Phelan to argue that 
socioeconomic status affects multiple disease outcomes through multiple mechanisms by 
limiting access to both material and non-material resources.114 Stigmatization of health 
conditions, without the proper acknowledgement of the social forces that constrain agency and 
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contribute to vulnerability to disease, places those who are affected under a double burden of 
disease and stigmatization.  
Race, class, and gender 
It is notable that across time, disease, and continent, one can find instances in which 
stigma associated with health conditions has been used to not only make disparaging 
characterizations of individuals, but of groups of individuals based on their race, class, and 
gender. Many of there were actually motivated by negative social attitudes towards race, class, 
and gender that already existed in the society, and their association with stigmatized conditions 
was another indirect way to discriminate against minorities.  
Racial minorities have been regarded to be more prone to stigmatized health conditions 
because of a presumed innate or cultural inferiority. The anti-Semitic medical discourse of the 
late 19th century through mid-20th century characterized Jewish people as an overweight race.109 
This was associated with underlying assumptions about a behavioral flaw of over-consuming 
rich foods and alcohol, or a biological flaw of being predisposed to diabetes and excess weight 
gain. In China, leprosy became an embodiment of cultural backwardness of the south, based on 
the epidemiological understanding in the 16th-century when leprosy was mostly endemic in the 
southern, miasmatic region. Leung argues that these beliefs polarized the country, creating a 
“dividing  line  between…center  and  south…the  civilized  and  the  savage  that  continued into the 
modern period.”105 Even as recently as the Severe Acute Respiratory Syndrome (SARS) 
epidemic in 2003, the perceived linkage between SARS and ethnicity let to the irrational 
avoidance of Asians in many parts of the world.92 
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In addition, women have been believed to suffer from stigmatized diseases because of 
their comparatively weak composition and spirit. In China, leprosy was also believed to be the 
disease of morally base women, because it was thought to be transmitted sexually from female 
sufferers.105 In the United States, women in popular fiction and cartoons in the 19th century were 
featured as overweight, representing them as sexually loose, primitive and repulsive,115 and 
lacking in sufficient rational qualities to control the impulses of corporal desires.115 Notably, this 
tactic to mock women was used by women themselves. During the American suffrage 
movement, suffragist and anti-suffragist women ridiculed the members of the opposing group by 
exploiting the various unattractive associations of excess weight. In their propaganda posters, 
anti-suffragists aimed to portray the unflattering lack of femininity of the suffragists by depicting 
them as overweight. Meanwhile, suffragists used obesity to symbolize the old-fashioned and 
aging quality of anti-suffragists. In contrast, both parties portrayed themselves as thin, white and 
attractive.115 
In terms of social class, scholars have noted that the emergence weight bias coincided 
with the emergence of a middle class in the 19th century.109 Prior to this time, excess weight was 
seen as a privilege, a symbol of power and affluence accessible to very few as illustrated in the 
“fat  cat”  cartoons  of  rich,  powerful  men  with  a  large  belly.115 During the economic and social 
changes in the late 19th century, the American nouveau riche began to enjoy the new economic 
and social liberties previously reserved for the elite. Excess weight came to be associated with 
the lack of self-restraint demonstrated by the middle class: the cartoons mocked overweight 
middle-class people who can no longer fit in their suits or their swimming pools.115 
Some have implicated that health care providers have taken advantage of the stigmatized 
status of health conditions to assert their greater social status over patients. Gilman argues that 
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lay health practitioners and health and nutrition vendors have capitalized on the stigma of obesity 
to encourage dieting and attract overweight people as their clients 109. Luker, in her historical 
account of abortion in the United States, illustrates how anti-abortion physicians sought to frame 
the abortion debate by asserting that they had claim to superior scientific knowledge 116. The 
public acceptance of the technical basis of the claim gave doctors unquestioned legitimacy in the 
debate. Further, through creating and controlling a moral problem, physicians used the issue of 
abortion as a symbolic claim to superior moral status.116 In contrast, women were precluded from 
any effective challenge to medical control of abortion because they were defined as self-
interested parties whose vested interests in the outcome made them incapable of reaching an 
“objective”  decision.116 
Health-related stigma has functioned to strip individuals of their citizenship status in their 
communities. Gilman claims that societies have often considered that “healthy citizens are better 
citizens.”109 In her work, Farrell explored the historical connection between body size and the 
notion of citizenship, noting that the link between weight and citizenship is illustrated quite 
literally in American cartoons of the late 19th and early 20th century depicting immigrant laborers 
as overweight, stupid and clumsy.115 Not only were people with a disease not worthy of 
membership, but they also were thought to actively corrupt the rest of the state. Leung uses the 
metaphor  of  a  “physically  [and]  socially  corrupt  body  that  threatened  to  pollute the healthy part 
of  society”  to  characterize  the  attitude  towards  leprosy  patients.105 Leung argues that, to the rest 
of  the  world,  leprosy  in  China  embodied  two  “defects”  of  the  Chinese  race:  its physical 
inferiority and the contagiousness of its disease.105 
 So strong was the fear, repulsion, and pity that the stigmatized provoked in others that it 
gave them a strange form of power in certain contexts. Leprosy suffers in China formed groups 
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at the margins of society, and extorted money from others by refusing to leave from celebratory 
events or funerals unless they were paid, or worked for pirates and gangsters to retrieve ransom 
from families of kidnapped person.105 At times, stigmatized diseases also served to inspire 
compassion in other people. An epileptic  was  “considered  a  poor  wretch,  deserving  pity,  
compassion, and special consideration.”  Beggars across Europe feigned epilepsy as early as the 
Middle Ages, prisoners feigned epilepsy to evade torture, and men feigned epilepsy to evade 
universal military conscription.106 
Stigma and social structure 
Link and Phelan propose that stigmatization is contingent on a social structure in which 
there is differential access to social, economic, and political power that determines who is 
stigmatized by whom in a given society.117 Castro and Farmer propose a framework for 
understanding stigma through the large-scale social inequalities rooted in historical and 
economic processes. Using the example of HIV/AIDS, they argue that social forces such as 
racism, poverty, gender inequality – termed structural violence - determine not only who is more 
vulnerable to disease but also who has access to health care and who ultimately suffers from 
stigma and discrimination.82 Farmer’s  ethnographic  research showed that stigma in rural Haiti 
resulted  from  people’s  belief  that  AIDS  was  an  inevitable and fatal disease, a reflection and 
result of the complete lack of health care for the poor (AIDS and Accusations, Chapter 5, Haiti to 
Rwanda). Wolfe and colleagues found in Bostwana that respondents who perceived that 
antiretroviral therapy was available had significantly lower odds of having stigmatized attitudes 
toward HIV/AIDS 83. Farmer further states that HIV stigma has shaped the social response to 
AIDS by blaming the victims of AIDS and limiting further action. (AIDS and Accusations, 
Chapter 5, Haiti to Rwanda).   
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While social inequalities generate stigma, stigma continues to perpetuate and exacerbate 
these disparities. Yang and Kleinman describe stigma as a process that threatens social standing 
and the subsequent access to social resources, which they argue is what matters most to 
individuals in the local social context. 118 In China, an individual must cultivate the ability to 
engage in appropriate, reciprocal social exchanges in the family and community to be considered 
a full person. People with HIV/AIDS and schizophrenia are deemed no longer able to fulfill 
these interpersonal and intrapersonal obligations, and because fulfilling these norms of 
reciprocity define the moral status of the individual in the community, these individuals are 
treated as a non-person. These individuals face severe social sanctions and isolation from their 
families and communities – what they call a “social  death.” Stigma has been found to profoundly 
limit the ability of the affected person to seek and maintain social resources in other settings as 
well. Disclosure is essential for people living with HIV/AIDS to receive social support. Yet, fear 
of becoming targets of stigmatization prevents them from disclosing their status to their social 
networks,26 and the greater their shame and guilt, the more likely they are to avoid disclosure and 
interactions with others.71,72 HIV stigma has been correlated with depression,28 which may also 
limit their capacity for forming and maintaining social relationships. Takada and colleagues 
found that people living with HIV/AIDS who report experiences of discrimination and 
abandonment are more likely to lose their social support, consistent with the idea that friends and 
family members, who provide the bulk of social support, leave them because they become targets 
or stigma or are themselves sources of discrimination.  
The lived experience of stigma 
Scholars have developed measures to understand the complex experience of health-
related stigma for a variety of health conditions and adapted them for a range of cultural 
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contexts.111,119,120 Among them are the scales used to study HIV-related stigma in the clinical 
epidemiology literature that conceptualizes stigma as composed of interpersonal and 
intrapersonal dimensions.26,28,29,50,121 In these scales, enacted stigma refers to acts of 
discrimination and hostility directed at the stigmatized person because of his or her stigmatized 
status, normative stigma refers to the subjective awareness of stigma and the belief about the 
prevalence of stigmatizing attitudes among people in the local community, and internalized 
stigma refers to the extent to which an individual perceives stigma to be valid; in the case of 
stigmatized individuals, it is self-stigma, including feelings of guilt, shame, and worthlessness.50 
Each component is measured using its own scale. For example, the internalized stigma scale asks 
about feelings of guilt, shame, and worthlessness for being HIV-positive. Each of these 
dimensions have been shown to be related through other psychosocial factors that affect the 
wellbeing of people living with HIV/AIDS such as social support, depression, and disclosure 
avoidance.28,29,50,121  
While these scales have been meticulously developed based on theoretical frameworks of 
stigma and exploratory qualitative interviews, then tested for construct validity, they cannot 
sufficiently capture the lived experience of stigma as well as autobiographical accounts that have 
been written by those who have lived with stigmatized conditions. These accounts of the fear, 
shame, loneliness and humiliation shows that living with stigma is an experience of significant 
suffering.  
 For Jamison, the diagnosis of bipolar disorder signified the loss of her sense of identity as 
a confident, self-reliant person. She vividly describes when she first sought diagnosis of her 
illness as being “paralyzed  with  fear  and  shame,”  and “terribly  shattered in all of my notions of 
myself.”122 She lived in denial of her condition and was reluctant to adhere to her medications 
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for many years, despite being a clinical psychologist herself. Jamison’s  reluctance  to  disclose  her 
conditions to others stemmed from her fear of the consequences it would have on her 
professional career, and her anticipation of rejection from colleagues and friends. In one 
instance, Jamison refused hospitalization for the fear that if it were to become known, she would 
lose her clinical responsibilities.122 She encountered two heartbreaking rejections by her friends 
and family: first from her sister who  was  “disgusted”  that  Jamison  relied  on  medication,  and  then  
from  a  close  colleague  who  expressed  he  was  “deeply  disappointed”  when  she  confided  in  him  
her diagnosis.122  
 Monette recounts the experience of caring for someone with AIDS in the mid-1990s 
United States,  when  the  notion  of  AIDS  had  turned  into  “an  inquisition in the gay 
community.”123 Monette describes his rollercoaster life, one moment filled with hope for the 
availability of a new treatment, the next moment facing the loss of his friends to AIDS and the 
possibility of his  partner’s impending death to the disease. Discrimination and social isolation 
were routine to the experience of living with HIV, from health care workers who reacted in 
horror and refuse to mention the word AIDS, to his  partner’s  client who found out and left his 
partner’s  legal  practice. Monette poetically calls the social isolation of living with HIV as being 
“exiled  on  the  moon,”  an  experience  that  cannot  be  fully  understood except by those who are his 
“fellow  exiles.”123 He and his  partner’s  brother  withheld information about his partner’s  
diagnosis from his parents until his partner reached the later stages of AIDS and the disclosure 
became inevitable. Further debilitating was that Monette and his partner lived under a two-fold 
secrecy, a  “double  closet”  of  being  homosexual  and  being  HIV-positive.123  
Sontag argues that society assigns meanings to diseases, and that these meanings lead to 
harmful assumptions about the person affected. Although she refrains from mentioning her 
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personal experiences, her account is perhaps colored by her experience of undergoing breast 
cancer treatment at the time of writing. Sontag describes that society believed that having a 
tumor was shameful. People with repressed negative feelings, who  were  “losers of society,” 
became affected by cancer, and as the person was dying of cancer, he or she was “robbed  of  all  
capacities of self-transcendence.”  The language surrounding cancer captured these negative 
attitudes: cancer was associated with predatory and warlike terms such as “ruthless  invasion”  and  
“fight,”  and itself has been used as a metaphor to signify political corruption. Ultimately, she 
argues that,  “illness  is  not a  metaphor,  and  that  the  most  truthful  way  of  regarding  illness”  is  one 
without  “metaphoric  thinking.”110 
STIGMATIZATION IN HEALTH POLICY 
Stigmatization operates explicitly or implicitly in public health campaigns that aim to 
discourage unhealthful behaviors. One of the most familiar examples is the American anti-
tobacco campaign. In 1978, one of the earliest installments of  American  Cancer  Society’s  
Annual Great American Smokeout Campaign championed the slogan,  “Kissing  a  smoker is like 
licking an ashtray,” that remains in the memories of adults even today.124,125 While more recent 
campaigns have been less explicit,126 scholars and media alike nevertheless raise concern that 
anti-smoking policy in the United States has the potential to contribute to stigmatization by 
shaming smokers and sending symbolic messages of moral condemnation.111,125 Stigmatization 
may have more impact in resource-poor settings with limited access to informational and 
educational resources: India, Khale and Dyalchand implemented a rural sanitation program that 
engenders a sense of shame regarding open defecation and encourages communities to address it 
themselves.127 
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Some argue that public health policies that reprehend health behaviors do not necessarily 
lead to stigmatization. Stuber and colleagues found that, despite wide-spread implementation of 
anti-smoking legislation in the US, less than a majority of American smokers perceive smoker-
related stigma.128 Evidence have suggested that the immediate social network matters more than 
policy: smokers who were exposed to smoke-free air laws reported lower levels of smoker-
related stigma, while smokers whose friends and family found smoking unacceptable reported 
high levels of stigma.111  
 The effectiveness of these policies on health outcomes is mixed. Some public health 
approaches that stigmatize health conditions and behaviors have shown significant impact in 
reducing harmful health behaviors. Alamar and Glantz calculated a state-level social 
unacceptability  index  of  smoking  based  on  residents’  support  of  smoke-free laws, and found a 
10% increase in social unacceptability corresponded to a 3.7% decrease in cigarette consumption 
in the state.129 While smokers who perceive devaluation engage in social withdrawal from non-
smokers and keep secrets about smoking, they found that secrecy was correlated with a higher 
intention to quit smoking.128 In Khale and Dyalchand’s  rural sanitation program, villages that 
used shame to discourage open defecation had on average a higher rate of toilet use compared to 
villages that used the traditional sanitation program based on the provision of sanitation 
hardware.127  
In general, psychological research has found that using punishment tactics such as shame 
does not lead to lasting behavior change, and intervention research confirms this hypothesis. The 
weight bias literature overwhelmingly suggests that stigma contributes to psychological distress 
and unhealthy behaviors in both community and clinical populations.93 For currently overweight 
and obese participants, experiences of stigmatization were all significantly related to greater 
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body image dissatisfaction, lower self-esteem, greater social anxiety, more depression, and less 
life satisfaction.130 Stigma experiences and internalization of weight-based discrimination did not 
predict engagement in weight loss strategies and was found to be associated with higher 
frequency of binge-eating.131  
HIV stigma is also a well-documented barrier to the health and well-being of people 
living with HIV/AIDS (PLWHA). HIV-stigma has been associated with delaying or avoidance 
of HIV testing,61,62 poor adherence to HIV antiretroviral treatment,30 and poor engagement with 
care.31 In addition, PLWHA experience numerous mental and psychological sequelae of stigma, 
including stress, fear, anxiety, and depression.26-29 
Even in rare situations in which stigmatizing interventions are medically justified, the 
public health benefits must be weighed with the consequences of discrimination. While isolation 
and quarantine were absolutely necessary in the control of SARS in Hong Kong, those 
quarantined became targets of discrimination and social isolation, leading them to lose 
employment opportunities, be denied essential services, and become isolated from relationships 
that provided emotional and financial support.132 In enacting such public health interventions, 
Kleinman and Lee argue that it is critical to work toward limiting their negative social and 
psychological consequences as much as possible.  
Lessons from the history of public health have shown that stigmatization of those who are 
already vulnerable exacerbates morbidity and mortality by erecting barriers between health 
services and those who are sick. The antivenereal disease campaigns by the United States during 
World War I resulted in justifying breaches in civil liberties in the name of public health, 
including the quarantine and incarceration of thousands of women who were suspected of 
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spreading venereal disease.133 Despite these draconian efforts, they failed to serve as an effective 
public health measure, as the rates of disease remained high during the war. Furthermore, the 
military declined to distribute condoms for fear that it would encourage promiscuity, despite the 
evidence that they prevented infection. Brandt attributes the failure to the infusion of public 
health with the social hygiene movement of the 20th century, professing moral concern regarding 
sexuality and the notion of responsibility for contracting the disease, and that the best way to 
prevent infection was by adhering to a sexual ethic that made it impossible to acquire infection.  
Public health approaches that stigmatize the individual for their health condition can be 
problematic for several reasons. By implying the individual has responsibility to change, these 
approaches neglect the complexity of health behaviors that are deeply embedded in social, 
cultural, and economic structures, as well as biological processes. This misplaced emphasis on 
individual responsibility may deny broader social responsibilities for health and disease.108 
Similarly,  Becker  contends  that  public  health  messaging  about  obesity  “conflates  health  literacy  
with  health  agency,”  assuming  individual  actors  have responsibility, autonomy, and agency to 
manage behavior that is not entirely within the control of the individual.87 This approach fails to 
take into account the psychological complexity of motivation, and the impact of the social 
environment and norms that create risk for stigmatized conditions. Moreover, stigmatization 
harms the health of those who are stigmatized by creating a barrier to health services, and 
causing social isolation and profound psychosocial distress. Ultimately, stigmatization must be 
addressed in health and social policy, not only for the wellbeing of those with stigmatized health 
conditions, but also to achieve positive public health outcomes.132 
CONCLUSION 
 Social psychologists describe stigma as originating from an unsympathetic interaction 
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between a person possessing a non-normative trait, and a cynical, authoritarian person who 
wishes to justify their social values. The stigmatizing response may have evolutionary roots in 
letting an individual detect people who pose fitness burdens. However, situating stigma in the 
social space reveals that health-related stigma is based on reductionistic explanations of disease 
causation, and is intimately tied to disparities in access to social, political, and economic 
resources. Furthermore, health policies that promote stigmatization not only fail to demonstrate 
outcomes in improving health, but also serve to harm those who are targets of stigma. Taken 
together, the use of health-related stigma in health and social policy represents a lack of 
acknowledgement of the social forces that shape the social distribution of disease as well as 
stigmatization.  Further, the societal failure to acknowledge the suffering caused by 
stigmatization becomes in itself another form of suffering. Kleinman and colleagues argue that 
one may be unable to experience the pain of another because of the asymmetry of access to 
experiential knowledge, but this inability to experience pain is distinct from the inability to 
acknowledge their pain.134 In this sense, the lack of acknowledgement of the suffering caused by 
stigmatization by policymakers in particular and society in general adds an additional layer of 
socially produced suffering to the experience of the stigmatized. Therefore, societies have a 
responsibility to be wary of enacting policies that stigmatize and normalize stigmatization, 
because they exacerbate the social and economic disparities that underlie stigmatization and 
cause unnecessary suffering to those who already suffer from their illnesses.  
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